<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="pt" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">Rev Lat Am Enfermagem</journal-id>
			<journal-id journal-id-type="publisher-id">rlae</journal-id>
			<journal-title-group>
				<journal-title>Revista Latino-Americana de Enfermagem</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Rev. Latino-Am. Enfermagem</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="epub">1518-8345</issn>
			<issn pub-type="ppub">0104-1169</issn>
			<publisher>
				<publisher-name>Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="other">00604</article-id>
			<article-id pub-id-type="doi">10.1590/1518-8345.5663.3567</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Artigo de Revisão</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Efeito da termometria na prevenção de úlceras de pé diabético: revisão sistemática com metanálise</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-0100-0147</contrib-id>
					<name>
						<surname>Araújo</surname>
						<given-names>Açucena Leal de</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-3150-2540</contrib-id>
					<name>
						<surname>Negreiros</surname>
						<given-names>Francisca Diana da Silva</given-names>
					</name>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-3119-7187</contrib-id>
					<name>
						<surname>Florêncio</surname>
						<given-names>Raquel Sampaio</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-3902-8046</contrib-id>
					<name>
						<surname>Oliveira</surname>
						<given-names>Shérida Karanini Paz de</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-5087-4310</contrib-id>
					<name>
						<surname>Silva</surname>
						<given-names>Ana Roberta Vilarouca da</given-names>
					</name>
					<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-1424-0649</contrib-id>
					<name>
						<surname>Moreira</surname>
						<given-names>Thereza Maria Magalhães</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>1</label>
				<institution content-type="original"> Universidade Estadual do Ceará, Fortaleza, CE, Brasil.</institution>
				<institution content-type="normalized">Universidade Estadual do Ceará</institution>
				<institution content-type="orgname">Universidade Estadual do Ceará</institution>
				<addr-line>
					<city>Fortaleza</city>
					<state>CE</state>
				</addr-line>
				<country country="BR">Brazil</country>
			</aff>
			<aff id="aff2">
				<label>2</label>
				<institution content-type="original"> Bolsista da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brasil.</institution>
				<institution content-type="orgname">Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)</institution>
				<country country="BR">Brasil</country>
			</aff>
			<aff id="aff3">
				<label>3</label>
				<institution content-type="original"> Universidade Federal do Ceará, Fortaleza, CE, Brasil.</institution>
				<institution content-type="normalized">Universidade Federal do Ceará</institution>
				<institution content-type="orgname">Universidade Federal do Ceará</institution>
				<addr-line>
					<city>Fortaleza</city>
					<state>CE</state>
				</addr-line>
				<country country="BR">Brazil</country>
			</aff>
			<aff id="aff4">
				<label>4 </label>
				<institution content-type="original">Universidade Federal do Piauí, Picos, PI, Brasil.</institution>
				<institution content-type="normalized">Universidade Federal do Piauí</institution>
				<institution content-type="orgname">Universidade Federal do Piauí</institution>
				<addr-line>
					<city>Picos</city>
					<state>PI</state>
				</addr-line>
				<country country="BR">Brazil</country>
			</aff>
			<aff id="aff5">
				<label>5</label>
				<institution content-type="original"> Bolsista do Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brasil.</institution>
				<institution content-type="orgname">Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)</institution>
				<country country="BR">Brasil</country>
			</aff>
			<author-notes>
				<corresp id="c1">
					<label>Autor correspondente:</label> Açucena Leal de Araújo. E-mail: <email>a.leal09@hotmail.com</email>
				</corresp>
				<fn fn-type="edited-by" id="fn1">
					<label>Editora Associada</label>
					<p> Maria Lúcia Zanetti</p>
				</fn>
				<fn fn-type="con" id="fn3">
					<label>Contribuição dos autores</label>
					<p><bold>Concepção e desenho da pesquisa:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Thereza Maria Magalhães Moreira. <bold>Obtenção de dados:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Raquel Sampaio Florêncio, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva. <bold>Análise e interpretação dos dados:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Raquel Sampaio Florêncio, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva, Thereza Maria Magalhães Moreira. <bold>Análise estatística:</bold> Açucena Leal de Araújo, Raquel Sampaio Florêncio, Thereza Maria Magalhães Moreira. <bold>Redação do manuscrito:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva, Thereza Maria Magalhães Moreira. <bold>Revisão crítica do manuscrito quanto ao conteúdo intelectual importante:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Raquel Sampaio Florêncio, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva, Thereza Maria Magalhães Moreira. Todos os autores aprovaram a versão final do texto.</p>
				</fn>
				<fn fn-type="conflict" id="fn4">
					<label>Conflito de interesse</label>
					<p> Os autores declararam que não há conflito de interesse.</p>
				</fn>
			</author-notes>
			<pub-date date-type="collection" publication-format="electronic">
				<year>2022</year>
			</pub-date>
			<pub-date date-type="pub" publication-format="electronic">
				<day>16</day>
				<month>05</month>
				<year>2022</year>
			</pub-date>
			<volume>30</volume>
			<elocation-id>e3567</elocation-id>
			<history>
				<date date-type="received">
					<day>23</day>
					<month>08</month>
					<year>2021</year>
				</date>
				<date date-type="accepted">
					<day>16</day>
					<month>01</month>
					<year>2022</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="pt">
					<license-p>Este é um artigo publicado em acesso aberto sob uma licença Creative Commons</license-p>
				</license>
			</permissions>
			<abstract>
				<title>Resumo</title>
				<sec>
					<title>Objetivo:</title>
					<p> analisar o efeito da termometria podálica cutânea em pessoas com diabetes mellitus, comparado com prevenção padrão de úlceras podálicas adotada nesses pacientes.</p>
				</sec>
				<sec>
					<title>Método:</title>
					<p> revisão sistemática com metanálise. Protocolo registrado na PROSPERO (CRD42020202686). Foram seguidas as recomendações do <italic>Preferred Reporting Items for Systematic Reviews and Meta-Analyses</italic> (PRISMA). Busca realizada nas fontes de dados: SCOPUS, <italic>Web of Science</italic>, MEDLINE via PubMed, MEDLINE via EBSCO, MEDLINE via Biblioteca Virtual em Saúde, Embase, CINAHL, <italic>Cochrane Library</italic>, LILACS via Biblioteca Virtual em Saúde, <italic>Google Scholar</italic>, Biblioteca Digital Brasileira de Teses e Dissertações, Catálogo de Teses &amp; Dissertações-Capes, <italic>Open Grey</italic> e <italic>ProQuest Dissertations and Theses</italic>. O risco de viés foi avaliado pela <italic>Cochrane Collaboration Risk of Bias Tool</italic> (RoB 2), a metanálise no <italic>software Review Manager</italic> 5.4 e a Certeza da evidência no sistema <italic>Grading of Recommendations Assessment, Development and Evaluation</italic>. </p>
				</sec>
				<sec>
					<title>Resultados:</title>
					<p> dos 670 registros, cinco artigos eram elegíveis. A metanálise foi calculada para o desfecho prevenção da incidência de úlceras de pé diabético, com sumarização de efeito (RR 0,53; IC95% 0,29, 0,96; p=0,02), com certeza da evidência moderada. </p>
				</sec>
				<sec>
					<title>Conclusão:</title>
					<p> a termometria mostrou efeito protetor na incidência de úlceras de pé diabético, se comparada ao cuidado podálico padrão.</p>
				</sec>
			</abstract>
			<kwd-group xml:lang="pt">
				<title>Descritores:</title>
				<kwd>Diabetes Mellitus</kwd>
				<kwd>Termometria</kwd>
				<kwd>Pé Diabético</kwd>
				<kwd>Prevenção de Doenças</kwd>
				<kwd>Enfermagem</kwd>
				<kwd>Revisão Sistemática</kwd>
			</kwd-group>
			<counts>
				<fig-count count="9"/>
				<table-count count="6"/>
				<equation-count count="0"/>
				<ref-count count="34"/>
				<page-count count="0"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<boxed-text id="bx1">
			<sec>
				<title>Destaques</title>
				<p>(1) As úlceras de pé diabético são precedidas pelo aumento da temperatura dérmica local.</p>
				<p>(2) A termometria pode auxiliar na identificação precoce de inflamação/ulceração.</p>
				<p>(3) Medições de temperatura podem ser facilmente realizadas pelos pacientes/familiares.</p>
				<p>(4) A termometria pode contribuir com a redução da sobrecarga dos serviços de saúde.</p>
				<p>(5) A eficácia da termometria está apoiada em certeza da evidência moderada.</p>
			</sec>
		</boxed-text>
		<sec sec-type="intro">
			<title>Introdução</title>
			<p>As atuais abordagens adotadas pelos serviços de saúde na prevenção e tratamento precoce das Úlceras de Pé Diabético (UPD) são múltiplas e variadas. O rastreamento, educação em saúde do paciente, família e profissionais da saúde são pilares relevantes<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>. Entretanto, esforços para prevenção da UPD permanecem um desafio e demandam altos custos à saúde pública mundial<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref>, suscitando necessidade de novas abordagens preventivas.</p>
			<p>As UPD são precedidas de aumento da temperatura dérmica local pela inflamação e autólise enzimática do tecido decorrente do desequilíbrio pressão-atividade, somado ao estresse repetitivo, perda sensorial neuropática e anormalidades biomecânicas<xref ref-type="bibr" rid="B4"><sup>4</sup></xref>. Diferença de temperatura de 2,2ºC entre o mesmo ponto de ambos os pés supõe risco de úlcera/inflamação iminente<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>. Entretanto, sinais clínicos de inflamação são sutis para sua detecção pelos pacientes ou até por profissionais de saúde treinados<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>. Embora muitos sinais de inflamação sejam difíceis de avaliar objetivamente, a temperatura pode ser facilmente medida. </p>
			<p>O método tradicional de avaliação da temperatura podálica consiste na palpação com o dorso da mão. Entretanto, com esse método, o ser humano só é capaz de discriminar diferenças de temperatura maiores que 2ºC. Assim, a termometria cutânea emerge como ferramenta promissora de identificação da inflamação, fornecendo sinais precoces para prevenir incidência de UPD e reduzir complicações graves, a exemplo de alta morbidade, frequentes hospitalizações, amputação de extremidades inferiores e óbitos<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref>. É o método mais usado pela comunidade científica e pacientes, pois envolve uso de termômetro, instrumento de fácil aplicação e baixo custo<xref ref-type="bibr" rid="B10"><sup>10</sup></xref>. Com isso, pacientes podem modificar sua atividade, mensurando a temperatura da pele, assim como dosam sua insulina e verificam sua glicemia<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>.</p>
			<p>Estudo relatou associação entre aumento da temperatura local e pressão localizada, gerando lesão tecidual<xref ref-type="bibr" rid="B12"><sup>12</sup></xref>. Pesquisadores utilizaram a termometria como ferramenta para diagnosticar fraturas neuropáticas ocultas em pacientes com diabetes<xref ref-type="bibr" rid="B13"><sup>13</sup></xref>. A avaliação da temperatura é técnica útil para identificar pacientes em risco de ulceração<xref ref-type="bibr" rid="B14"><sup>14</sup></xref>. Achados semelhantes foram identificados com termômetro infravermelho portátil em pacientes com neuropatia sensorial assintomática, úlceras neuropáticas podálicas e pacientes com fraturas neuropáticas (artropatia de Charcot)<xref ref-type="bibr" rid="B15"><sup>15</sup></xref>.</p>
			<p>A temperatura podálica varia com o nível de atividade do paciente e o ambiente. A referência é uma área correspondente no pé contralateral. Vale ressaltar que as temperaturas dessas áreas não diferem em mais de 1ºC<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref> e estudos sugerem que diferenças de ≥ 2,2ºC na temperatura podem ser consideradas risco de ulceração<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref>.</p>
			<p>Mundialmente, três Ensaios Clínicos Controlados Randomizados (ECR) testaram o automonitoramento da temperatura cutânea podálica em pessoas com diabetes mellitus e seu risco de ulceração, via termometria infravermelha cutânea como sinal de alerta da iminência de úlcera. Esses estudos mostraram redução significativa da incidência de novas úlceras podálicas<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>.</p>
			<p>Revisões sistemáticas anteriores analisaram o efeito de várias intervenções para prevenção de úlcera de pé diabético, entre elas o uso do monitoramento térmico dos pés<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref>. Embora tenham sido identificadas revisões sobre o assunto, observou-se falhas em fornecer resumos numéricos confiáveis dos efeitos devido às limitações da qualidade dos estudos individuais. Além disso, novas evidências surgiram desde então. Assim, uma avaliação abrangente dos ensaios clínicos randomizados foi necessária para nos permitir fazer o melhor uso das evidências atualmente disponíveis.</p>
			<p>Esta revisão sistemática com metanálise teve como objetivo analisar o efeito da termometria podálica cutânea em pessoas com Diabetes Mellitus (DM), comparado com prevenção padrão de úlceras podálicas adotada nesses pacientes. </p>
		</sec>
		<sec sec-type="methods">
			<title>Método</title>
			<sec>
				<title>Protocolo e registro</title>
				<p>Trata-se de revisão sistemática da literatura, segundo critérios do <italic>Preferred Reporting Items for Systematic Reviews and Meta-Analyses</italic> (PRISMA)<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. Este tipo de estudo sumariza evidências provenientes de estudos primários, conduzidos para responder uma questão específica de pesquisa. Utiliza processo de revisão de literatura abrangente, imparcial e reprodutível, e localiza, avalia e sintetiza o conjunto de evidências dos estudos científicos para obter visão geral e confiável da estimativa do efeito da intervenção<xref ref-type="bibr" rid="B23"><sup>23</sup></xref>.</p>
				<p>Esta revisão teve seu protocolo previamente publicado na plataforma <italic>International Prospective Register of Systematic Reviews</italic> (PROSPERO) da <italic>York University</italic>, com número de registro CRD42020202686, obtido no dia 4 de setembro de 2020.</p>
			</sec>
			<sec>
				<title>Pergunta de pesquisa e critérios de elegibilidade</title>
				<p>A estratégia <italic>Population, Intervention, Control</italic> e <italic>Outcome</italic> (PICO) foi usada para a pesquisa de dados<xref ref-type="bibr" rid="B24"><sup>24</sup></xref>. Esta revisão sistemática com metanálise focou em participantes (P) com diagnóstico de diabetes mellitus, com ou sem risco de desenvolver úlcera de pé diabético. O uso de dispositivos de termometria cutânea para avaliar temperatura podálica foi disposto como intervenção (I). O uso do cuidado de saúde padrão com os pés (calçados terapêuticos, educação do pé diabético, avaliação regular dos pés pelos profissionais de saúde e autocuidado com os pés) foi disposto como comparação (C). E os resultados avaliados (O) foram estudos que trouxeram o desfecho prevenção da incidência de úlceras de pé diabético. </p>
				<p>A partir disso, foi delineado o problema de pesquisa: Qual o efeito da termometria podálica cutânea em pessoas com DM, comparado com a prevenção padrão de úlceras podálicas adotada nesses pacientes?</p>
				<p>Os estudos eram incluídos quando atendessem aos critérios: diagnóstico de DM, idade ≥ 18 anos, ensaio clínico com grupo intervenção com termometria na prevenção de Úlceras de Pé Diabético (UPD) e grupo controle com cuidado padrão de saúde. Não foram adotadas restrições quanto ao idioma e ano de publicação, nem quanto a ter ou não risco de UPD (conforme estratificação do <italic>International Working Group On The Diabetic Foot</italic>)<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>. Descartamos publicações com: intervenção do estudo com termometria cutânea podálica em pessoas com e sem DM; termometria em pessoas com diabetes mellitus e úlcera ativa simultaneamente; desenho do estudo: transversal, coorte prospectiva e retrospectiva, caso-controle, relatórios de casos ou séries de casos; tipos de publicação: revisões, protocolos, carta ao editor, resumos de congressos, opiniões pessoais, capítulo de livros; indisponível na íntegra.</p>
			</sec>
			<sec>
				<title>Busca em fonte de dados</title>
				<p>A busca foi realizada nas bases de dados e literatura cinzenta no dia 26 de julho de 2020, sem restrições de idioma e ano. Uma atualização das buscas nas fontes de dados foi realizada no dia 21 de novembro de 2021. Foi consultado um bibliotecário familiarizado com a área de ciências da saúde ao desenvolver e conduzir a pesquisa. </p>
				<p>As bases de dados utilizadas foram: SCOPUS, <italic>Web of Science</italic>, MEDLINE (<italic>Medical Literature Analysis and Retrieval System Online</italic>) via PubMed, MEDLINE (<italic>Medical Literature Analysis and Retrieval System Online</italic>) via EBSCO, MEDLINE (<italic>Medical Literature Analysis and Retrieval System Online</italic>) via Biblioteca Virtual em Saúde (BVS), Embase, CINAHL (<italic>Cummulative Index to Nursing and Allied Health Literature</italic>), <italic>Cochrane Library</italic> (<italic>The Cochrane Central Register of Controlled Trials</italic> - CENTRAL) e LILACS (Literatura Latino-Americana e do Caribe em Ciências da Saúde) via Biblioteca Virtual em Saúde (BVS). </p>
				<p>A fim de reduzir o viés de publicação e identificar o máximo possível de evidências relevantes também foram consultados os bancos de dados da literatura cinzenta: <italic>Google Scholar</italic>, Biblioteca Digital Brasileira de Teses e Dissertações (BDTD), Catálogo de Teses &amp; Dissertações - Capes, <italic>Open Grey</italic> e <italic>ProQuest Dissertations and Theses</italic> (PQDT). </p>
				<p>Adicionalmente, fez-se necessária busca adicional pelas referências dos estudos incluídos. Também foi realizada busca adicional em consulta a “<italic>experts</italic>/especialistas” na área pesquisada via <ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/">https://www.researchgate.net/</ext-link>. Estes foram convidados a sugerir artigos relevantes sobre o tópico escolhido. No entanto, não foram obtidas respostas.</p>
			</sec>
			<sec>
				<title>Estratégia de busca</title>
				<p>A estratégia de busca foi construída utilizando três vocabulários controlados em saúde <italic>Medical Subject Headings</italic> (MeSH), Descritores em Ciências da Saúde (DeCS) e EMTREE em conjunto com a linguagem natural, a fim de se obter amplo espectro de resultados em diferentes bases de dados<xref ref-type="bibr" rid="B25"><sup>25</sup></xref>. Após definição dos termos de busca, eles foram combinados aos operadores booleanos AND e OR. </p>
				<p>A seguinte estratégica de busca de alta sensibilidade foi utilizada para todas bases de dados: (“diabetes mellitus” OR “diabetic patient” OR diabetes OR diabetic) AND (“temperature measurement” OR “temperature monitoring” OR “temperature recording” OR “thermal measurement” OR “thermal monitoring” OR “thermal recording” OR “thermo-monitoring” OR “thermo-recording” OR “body temperature monitoring” OR thermometer OR thermometry OR thermogram OR thermomonitoring OR thermorecording OR thermomeasurement) AND (prevention OR prevent OR control OR prophylaxis OR “prevent ulceration” OR “ulcer prevention” OR “prophylactic treatment” OR “preventive therapy” OR “preventive measures” OR “disease prevention” OR “disease prophylaxis” OR “health protection” OR “preventive treatment” OR “prophylactic management” OR “prophylactic therapy” OR “prophylactic treatment”) AND (foot OR ulcer OR ulceration OR feet OR “foot ulceration” OR “foot ulcer” OR “foot complication” OR “diabetic foot” OR “diabetic feet”).</p>
			</sec>
			<sec>
				<title>Seleção dos estudos e extração das informações</title>
				<p>Os resultados da pesquisa em cada base de dados foram importados para o gerenciador de referência Rayyan<sup>®</sup> desenvolvido pela <italic>Qatar Computing Research Institute</italic> (QCRI), para organização dos estudos, remoção de duplicatas, seleção e triagem dos estudos<xref ref-type="bibr" rid="B26"><sup>26</sup></xref>. Dois autores da revisão examinaram independentemente os títulos e resumos de todas as referências. Em seguida, os textos completos dos estudos potencialmente elegíveis foram avaliados independentemente pelos dois revisores para determinar se todos os critérios de inclusão foram atendidos. Em caso de discordâncias, o terceiro autor da revisão foi consultado.</p>
				<p>Os dados dos estudos selecionados para amostra final foram extraídos pelos dois revisores de forma independente e depois comparados. Utilizou-se ficha clínica padronizada criada no <italic>Microsoft Excel</italic><sup>®</sup> e, por fim, os dados coletados foram compilados em tabela. Os dados coletados foram: características do estudo (autor, ano, país, objetivo); características da população (amostra total, sexo, tipo de diabetes e média de idade), característica do grupo intervenção e grupo controle (local de recrutamento da amostra, duração em meses, número de participantes em cada grupo, descrição da intervenção e do controle), características do resultado (desfechos avaliados, principais resultados) e conclusão. Após, compararam-se os resultados da coleta, discutindo-se juntamente com o terceiro revisor o que realmente era relevante. Caso houvesse informações lacunosas, ambíguas, incompletas ou não descritas nos estudos primários, esforços foram feitos para contatar seus autores.</p>
				<p>O fluxograma do <italic>Preferred Reporting Items for Systematic Reviews and Meta-Analyses</italic> (PRISMA) foi utilizado para documentar a seleção dos estudos.</p>
			</sec>
			<sec>
				<title>Análise do risco de viés de estudos individuais</title>
				<p>A avaliação do risco de viés dos estudos incluídos foi analisada com a ferramenta <italic>Cochrane Collaboration Risk of Bias Tool</italic> (RoB 2) para estudos randomizados<xref ref-type="bibr" rid="B27"><sup>27</sup></xref>. A RoB 2 inclui juízos acerca da geração de sequência aleatória, ocultação de alocação, cegamento de participantes e pessoal, cegamento dos avaliadores de resultados, dados de resultados incompletos, relatório seletivo e outras fontes de vieses. Os estudos foram categorizados em grupos rotulados como baixo risco de viés, risco incerto de viés ou alto risco de viés.</p>
				<p>A RoB 2 tem a novidade de considerar que nem sempre o cegamento dos participantes é possível. Devemos rebaixar a qualidade da evidência apenas se a falta de cegamento afetar as intervenções de maneira desbalanceada entre os grupos e se afetar desfechos<xref ref-type="bibr" rid="B27"><sup>27</sup></xref>. O risco de viés foi realizado por dois revisores independentes. Em caso de discordâncias no julgamento dos dois revisores, foi solicitada avaliação do terceiro revisor.</p>
				<p>Para sintetizar a análise do risco de viés, a ferramenta <italic>Cochrane Collaborations’s Review Manager 5</italic> (RevMan 5.4), foi utilizada e permitiu construção do sumário do risco de viés<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. </p>
			</sec>
			<sec>
				<title>Síntese dos dados</title>
				<p>Realizou-se síntese descritiva das características dos estudos. A síntese quantitativa dos dados foi realizada em metanálise dos estudos considerados combináveis e homogêneos em relação às intervenções e resultados. O <italic>Cochrane Collaboration´s Review Manager</italic><sup>®</sup> 5 (RevMan 5.4)<xref ref-type="bibr" rid="B28"><sup>28</sup></xref> foi usado para executar a metanálise, apresentada por meio do gráfico <italic>Forest Plot</italic>. A heterogeneidade presente nos estudos foi avaliada pelo teste estatístico I2 de índices de inconsistência, considerando valor de 0-30% para heterogeneidade não importante, 31-50% heterogeneidade moderada, de 51-80% heterogeneidade substancial e entre 81-100% heterogeneidade considerável<xref ref-type="bibr" rid="B29"><sup>29</sup></xref>. Os resultados foram apresentados com intervalos de confiança de 95% (IC95%).</p>
				<p>Para realizar a metanálise, foi escolhido o modelo de efeito randômico<xref ref-type="bibr" rid="B29"><sup>29</sup></xref>. Como medida de efeito foi utilizada para desfechos binários (resultado pode ser 1 de 2 possibilidades) a Razão de Risco (RR, ou risco relativo), sendo considerada neste estudo a ocorrência ou não de úlcera de pé diabético. Quanto à estimativa de efeito dos estudos individuais, esta foi calculada pelo método estatístico de Mantel-Haenszel, ideal para estudos de tamanho amostral pequeno.</p>
			</sec>
			<sec>
				<title>Classificação da certeza da evidência</title>
				<p>Esta pesquisa utilizou o sistema <italic>Grading of Recommendations Assessment, Development and Evaluation</italic> (GRADE) da Cochrane para classificar a certeza da evidência<xref ref-type="bibr" rid="B30"><sup>30</sup></xref>. Os critérios avaliados foram o desenho do estudo, o risco de viés, a inconsistência, a evidência indireta, a imprecisão e outras considerações. A certeza da evidência pode ser caracterizada como alta, moderada, baixa ou muito baixa. Dispensou-se a construção de gráfico de funil para avaliação de presença de viés de publicação devido aos poucos ensaios clínicos randomizados serem inferior a dez. </p>
				<p>Foi confeccionada a tabela denominada “Perfil de Evidências GRADE”, para sumarizar os achados dessa avaliação. Nesse processo foi utilizada a ferramenta on-line GRADEpro GDT (<italic>Guideline Development Tool</italic>), acessada gratuitamente no <italic>website</italic><ext-link ext-link-type="uri" xlink:href="http://www.gradepro.org">http://www.gradepro.org</ext-link>. </p>
			</sec>
		</sec>
		<sec sec-type="results">
			<title>Resultados</title>
			<sec>
				<title>Características dos estudos incluídos</title>
				<p>No total, foram identificados 670 registros. Depois de remover as duplicatas, 373 foram deixados para triagem. Após triagem de títulos e resumos, 326 registros foram excluídos por não responderem aos critérios de inclusão, deixando 47 estudos potencialmente relevantes. Destes, 4 registros não foram recuperados na integra, restando 43 para triagem de texto completo. Após leitura na integra, 38 não atendiam aos critérios de elegibilidade, restando 5 estudos (<xref ref-type="fig" rid="f1">Figura 1</xref>). </p>
				<p>
					<fig id="f1">
						<label>Figura 1</label>
						<caption>
							<title>Fluxograma de busca conforme as recomendações do PRISMA<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>
							</title>
						</caption>
						<graphic xlink:href="1518-8345-rlae-30-e3567-gf1.png"/>
					</fig>
				</p>
				<p>Obteve-se como resultado final cinco Ensaios Clínicos Randomizados (ECR), com total de 828 participantes, conduzidos nos Estados Unidos<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>, Holanda<xref ref-type="bibr" rid="B31"><sup>31</sup></xref> e Noruega<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>, publicados em língua inglesa, entre 2004 e 2021. As características dos artigos revelam grupos constituídos em sua maioria de idosos, do sexo masculino, com diagnóstico de DM2, diabetes mellitus de longa duração e estratificação de alto risco para ulceração 2/3<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>.</p>
				<p>Os estudos tiveram seguimento variando entre seis e 18 meses. Todos estudos avaliaram uso da termometria em domicílio como método preventivo de úlceras diabéticas nos pés em comparação ao cuidado padrão de saúde. O dispositivo de termometria utilizado em todas intervenções foi o termômetro digital infravermelho portátil (<italic>TempTouch</italic>, <italic>Diabetica Solutions</italic>, San Antonio, Texas, EUA). Os controles utilizaram cuidado de saúde padrão com os pés (acompanhamento com profissionais da saúde, educação sobre cuidados com os pés, uso de calçados terapêuticos). A <xref ref-type="table" rid="t1">Figura 2</xref> resume as características dos estudos incluídos.</p>
				<p>
					<table-wrap id="t1">
						<label>Figura 2</label>
						<caption>
							<title>Características dos ECR incluídos na RS (n=5). Fortaleza, CE, Brasil, 2021</title>
						</caption>
						<table>
							<colgroup>
								<col/>
								<col/>
								<col span="3"/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left">Autor/ano/país</th>
									<th align="left">Características da amostra</th>
									<th align="left" colspan="3">Grupo Intervenção/Grupo Controle </th>
									<th align="left">Resultados principais</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td align="left">Armstrong, et al.<xref ref-type="bibr" rid="B16"><sup>16</sup></xref> 2007. Estados Unidos.</td>
									<td align="left">n=225 (GI*: 110, GC<sup>†</sup>: 115) Masculino: 96% Idade média: 69 anos DM2<sup>‡</sup>: 100% Duração média do DM: 13 anos Risco de úlcera: 2/3 (IWGDF<sup>§</sup>)</td>
									<td align="left">Duração: 18 meses Desfechos: Proporção de pacientes em cada grupo que desenvolveram úlceras nos pés</td>
									<td align="left">GI*: termômetro infravermelho portátil e registro em diário </td>
									<td align="left">GC<sup>†</sup>: calçados terapêuticos, educação sobre diabetes, cuidados regulares com os pés e registro em diário </td>
									<td align="left">Incidência de úlceras nos pés: GI*: 4,7% (n=5/NR<sup>||</sup>), GC<sup>†</sup>: 12,2% (n=14/NR<sup>||</sup>) </td>
								</tr>
								<tr>
									<td align="left">Bus, et al.<xref ref-type="bibr" rid="B31"><sup>31</sup></xref> 2021 Holanda</td>
									<td align="left">n=304 (GI*: 151, GC<sup>†</sup>: 153) Masculino: 72,4% Idade média: 65 DM2<sup>‡</sup>: 77% Duração média do DM: 20 anos Risco de úlcera: 2/3 (IWGDF<sup>§</sup>)</td>
									<td align="left">Duração: 18 meses Desfechos: Proporção de pacientes em cada grupo que desenvolveram úlceras nos pés</td>
									<td align="left">GI*: termômetro infravermelho portátil e registro em formulário padronizado desenvolvido pelo investigador.</td>
									<td align="left">GC<sup>†</sup>: avaliação dos pés e triagem dos pés uma vez a cada 1-3 meses por um podólogo; calçado terapêutico (se indicado) e educação sobre cuidados com os pés.</td>
									<td align="left">Incidência de úlceras nos pés: GI*: 29,1% (n=44/151), GC<sup>†</sup>: 37,3 % (n=57/153)</td>
								</tr>
								<tr>
									<td align="left">Lavery, et al.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> 2004. Estados Unidos.</td>
									<td align="left">n=85 (GI*: 44, GC<sup>†</sup>: 41) Masculino: 50% Idade média: 55 anos DM2<sup>‡</sup>: NR Duração média do diabetes: 14 anos Risco de úlcera: 2/3 (IWGDF<sup>§</sup>)</td>
									<td align="left">Duração: 06 meses Desfechos: Proporção de pacientes em cada grupo que desenvolveram úlceras nos pés, infecções, fraturas de Charcot e amputações</td>
									<td align="left">GI*: termômetro infravermelho portátil e registro em diário </td>
									<td align="left">GC<sup>†</sup>: calçados terapêuticos, educação sobre cuidados com os pés e avaliação regular por um podólogo a cada 10 a 12 semanas</td>
									<td align="left">Incidência de úlceras nos pés: GI*: 2% (n=1/44) GC<sup>†</sup>: 20% (n=9/41) (sete pessoas ulceraram e duas tiveram artropatias de Charcot)</td>
								</tr>
								<tr>
									<td align="left">Lavery, et al.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref> 2007 Estados Unidos</td>
									<td align="left">n=173 (GI1: 59, GI2: 56, GC: 58) Masculino: 54% Idade média: 65 anos DM2<sup>‡</sup>: 95% Duração média do diabetes: 13 anos Risco de úlcera: 2/3 (IWGDF<sup>§</sup>)</td>
									<td align="left">Duração: 15 meses Desfechos: Proporção de pacientes em cada grupo que desenvolveram úlceras nos pés</td>
									<td align="left">GI1: termômetro infravermelho portátil e registro em diário. GI2: espelho para autoinspeção dos pés duas vezes por dia e registro em diário </td>
									<td align="left">GC<sup>†</sup>: avaliação dos membros inferiores (médico), programa, calçados terapêuticos e avaliação de palmilhas (podólogo), pedômetro e registro em diário; inspecionar os pés diariamente</td>
									<td align="left">Incidência de úlceras nos pés: GI1: 8,5 (n=5/59) GI2: 30,4 (n=17/56) GC<sup>†</sup>: 29,3 (n=17/58)</td>
								</tr>
								<tr>
									<td align="left">Skafjeld, et al.<xref ref-type="bibr" rid="B28"><sup>28</sup></xref> 2015. Noruega</td>
									<td align="left">n=41 (GI*: 21, GC<sup>†</sup>: 20) Masculino: 56% Idade média: 58 anos DM2<sup>‡</sup>: 71% Duração média do diabetes: 18 anos Risco de úlcera: 3 (IWGDF<sup>§</sup>)</td>
									<td align="left">Duração: 12 meses Desfechos: Proporção de pacientes em cada grupo que desenvolveram úlceras nos pés</td>
									<td align="left">GI*: termômetro infravermelho portátil, registro em diário, aconselhamento baseado em teoria e pedômetro para registro de atividade física na primeira semana do estudo </td>
									<td align="left">GC<sup>†</sup>: inspeção diária dos pés e registro em diário; uso de calçados terapêuticos; entrar em contato com enfermeira, caso fossem observadas alterações</td>
									<td align="left">Incidência de úlceras nos pés: GI*: 39% (n=7/21) GC<sup>†</sup>: 50% (n=10/20)</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN1">
								<p>*GI = Grupo Intervenção; <sup>†</sup>GC = Grupo Controle; <sup>‡</sup>DM2 = Diabetes Mellitus tipo 2; <sup>§</sup>IWGDF = <italic>International Working Group on Diabetic Foot</italic>; <sup>||</sup>NR = Não Relatado</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
			</sec>
			<sec>
				<title>Avaliação do risco de viés</title>
				<p>Os dados foram analisados no <italic>software Review Manager</italic> 5.4<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. Conforme exposto na <xref ref-type="fig" rid="f2">Figura 3</xref>, apenas um estudo apresenta risco incerto de viés para “geração da sequência aleatória”<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. Em relação à “sequência de alocação”, um estudo apresenta alto risco de viés, por não mencionar a quantidade de participantes alocados para cada grupo<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. Por sua vez, dois dos estudos possuem risco incerto de viés, pois apresentam informações insuficientes<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref>. Um estudo apresentou risco incerto de viés para avaliação dos critérios de “relato seletivo”<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>.</p>
				<p>
					<fig id="f2">
						<label>Figura 3</label>
						<caption>
							<title>Resumo do risco de viés dos estudos incluídos</title>
						</caption>
						<graphic xlink:href="1518-8345-rlae-30-e3567-gf2.png"/>
					</fig>
				</p>
			</sec>
			<sec>
				<title>Síntese quantitativa dos estudos incluídos: metanálise</title>
				<p>Cinco ECR, envolvendo 828 participantes com diabetes foram identificados<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref>. Em um estudo<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>, o número de participantes randomizados para o grupo intervenção (termometria) e grupo controle (cuidado padrão de saúde) não foi mencionado e, portanto, não foi incluído na metanálise.</p>
				<p>Nesta metanálise, quatro ECR (n=547) foram incluídos, conforme apresentado no gráfico de <italic>Forest Plot</italic> (<xref ref-type="fig" rid="f3">Figura 4</xref>), sendo analisado o desfecho prevenção da incidência de úlceras de pé diabético, apresentado como desfecho binário. Evidenciou-se o efeito protetor da termometria, quando comparada ao cuidado podálico padrão para prevenção da incidência de úlcera de pé diabético (RR 0,53; IC95% 0,29-0,96; p=0,03). A heterogeneidade entre os estudos foi I<sup>2</sup>=55% (p=0,08). O número de pacientes necessários para tratar para prevenir o aparecimento de uma nova úlcera foi de 8 (IC95% = 5-19).</p>
				<p>
					<fig id="f3">
						<label>Figura 4</label>
						<caption>
							<title>Metanálise do efeito da termometria comparado com o cuidado padrão de saúde na prevenção da incidência de úlceras de pé diabético</title>
						</caption>
						<graphic xlink:href="1518-8345-rlae-30-e3567-gf3.png"/>
					</fig>
				</p>
			</sec>
			<sec>
				<title>Classificação da certeza da evidência</title>
				<p>O sistema <italic>Grading of Recommendations Assessment, Development and Evaluation</italic> (GRADE)<xref ref-type="bibr" rid="B30"><sup>30</sup></xref> foi usado para avaliar a certeza das evidências e resultados apresentados no perfil de evidências GRADE.</p>
				<p>A <xref ref-type="table" rid="t2">Figura 5</xref> apresenta avaliação da certeza da evidência da metanálise realizada conforme critérios previamente definidos pelo GRADE. Conforme o exposto, a estimativa do efeito da termometria para prevenção da incidência de úlceras de pé diabético foi de RR 0,53, comparada ao cuidado padrão de saúde, apoiando-se em evidência moderada.</p>
				<p>
					<table-wrap id="t2">
						<label>Figura 5</label>
						<caption>
							<title>Classificação da certeza da evidência sobre o efeito da termometria para prevenção de úlceras de pé diabético. GRADEpro GDT. Fortaleza, CE, Brasil, 2021</title>
						</caption>
						<table>
							<colgroup>
								<col span="7"/>
								<col span="2"/>
								<col span="2"/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="center" colspan="7">Avaliação da Certeza</th>
									<th align="center" colspan="2">Nº de pacientes </th>
									<th align="center" colspan="2">Efeito</th>
									<th align="center" rowspan="2">Certeza da evidência</th>
									<th align="center" rowspan="2">Importância </th>
								</tr>
								<tr>
									<th align="center">Nºdos estudos</th>
									<th align="center">Delineamento do estudo</th>
									<th align="center">Risco de viés</th>
									<th align="center">Inconsistência</th>
									<th align="center">Evidência indireta</th>
									<th align="center">Imprecisão</th>
									<th align="center">Outras considerações</th>
									<th align="center">Termometria cutânea</th>
									<th align="center">Cuidado padrão de saúde</th>
									<th align="center">Relativo (95% IC*)</th>
									<th align="center">Absoluto (95% IC*)</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td align="center" colspan="13">Prevenção da incidência de úlceras de pé diabético (seguimento: média 12,8 meses)</td>
								</tr>
								<tr>
									<td align="center">4</td>
									<td align="center">ensaios clínicos randomizados</td>
									<td align="center">não grave</td>
									<td align="center">não grave</td>
									<td align="center">não grave</td>
									<td align="center">grave<sup>†</sup></td>
									<td align="center">nenhum</td>
									<td align="center">57/275 (20.7%)</td>
									<td align="center">91/272 (33.5%)</td>
									<td align="center">RR<sup>‡</sup> 0.53 (0.29 para 0.96)</td>
									<td align="center">16 menos por 100(de 24 menos para 1 menos)</td>
									<td align="center">ꚚꚚꚚꚚОModerada</td>
									<td align="center">IMPORTANTE</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN2">
								<p>*IC = Intervalo de Confiança; <sup>†</sup>Baixo número de eventos; <sup>‡</sup>RR = Risco Relativo</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
			</sec>
		</sec>
		<sec sec-type="discussion">
			<title>Discussão</title>
			<p>Como a úlcera de pé diabético representa problema de saúde pública mundial, o uso de estratégias preventivas como termometria cutânea de pé pode contribuir na prevenção e agravos desta problemática. Entretanto, profissionais da saúde e pacientes precisam de evidências sólidas para implantar novos modelos de atendimento. Por isso, conduzimos RS sobre efeito da termometria na prevenção de UPD.</p>
			<p>Revisões sistemáticas anteriores sobre o assunto foram publicadas, todavia, observou-se inconsistências em relação à qualidade metodológica de estudo incluído em metanálises<xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref>. O ECR incluído nas metanálises não especifica quantos indivíduos foram alocados para o grupo intervenção (uso da termometria) e para o grupo controle (cuidado padrão de saúde)<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. Assim, observa-se falhas em fornecer resumo numérico confiável do efeito da intervenção. Além disso, buscas em fontes de dados e avaliação abrangente de novas evidências se fez necessário para fornecimento de informações confiáveis e robustas.</p>
			<p>A temperatura podálica era mensurada pelos pacientes duas vezes ao dia, em seis regiões específicas de cada pé (hálux, primeira, terceira e quinta cabeça do metatarso, mediopé e calcanhar). Em casos de amputações de um dedo do pé ou metatarso, a temperatura deveria ser medida em uma área anatômica adjacente. Diferenças de temperatura &gt;2,2ºC entre os locais correspondentes esquerdo e direito, por dois dias consecutivos, eram consideradas em risco de ulceração devido à inflamação no local de medição. Assim, os pacientes eram aconselhados a entrarem em contato com coordenador do estudo e reduzir atividade até a temperatura normalizar. Além disso, os pacientes deveriam realizar anotações em diário sobre observações da temperatura dos pés.</p>
			<p>Ao avaliar o desfecho (incidência de úlceras de PD), observa-se que em três estudos houve associação do monitoramento da temperatura com redução da taxa de ulceração, sugerindo que a termometria usada pelos pacientes auxilia na identificação precoce de inflamação plantar antes da ruptura da pele e formação da UPD<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. Em contrapartida, em dois estudos não foram detectadas diferenças entre grupo controle e intervenção<xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref>.</p>
			<p>No ECR conduzido por pesquisadores dos Estados Unidos, a incidência de UPD durante avaliação de 15 meses no grupo de cuidados habituais de saúde foi de 29,3%<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. Em contrapartida, no grupo que monitorava temperatura podálica nos mesmos pontos anatômicos diariamente, a incidência foi de 8,5% (OR 4,48; IC 95%; 1,53-13,14; p&lt;0,008). </p>
			<p>Em outra pesquisa conduzida pelo mesmo grupo de pesquisadores, houve complicações relacionadas à artropatia de Charcot (n=2)<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. No entanto, reconhece-se que a artropatia de Charcot ativa desempenha efeito individual na temperatura cutânea podálica. Por isso, dados dos casos de artropatia de Charcot foram excluídos da análise. Descobriu-se que, dos 84 indivíduos acompanhados durante seis meses, sete participantes do grupo de terapia padrão ulceraram. No entanto, no grupo com monitoramento da temperatura podálica, somente um indivíduo ulcerou (OR 8,00; IC95%). </p>
			<p>As medições de temperatura podem ser facilmente realizadas pelos pacientes ou familiares e podem representar um adjuvante eficaz na prevenção de UPD. Além disso, fornecem informações quantificáveis que demonstram formação de inflamação em regiões podálicas específicas e medidas preventivas podem ser adotadas antes da ruptura da pele. </p>
			<p>Demonstrou-se que 12,2% de 115 participantes do grupo com cuidado padrão ulceraram e apenas 4,7% de 110 indivíduos do grupo com termometria o fizeram<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. Termômetros portáteis podem demonstrar resultados positivos quando usados por pacientes de alto risco para prevenção de processos ulcerativos. Isso pode oferecer vantagem adicional às práticas e terapias convencionais de prevenção da UPD. </p>
			<p>Metade das 10 pessoas do grupo de cuidado padrão ulcerou e 39% das 21 pessoas do grupo de monitoramento da temperatura ulcerou, inexistindo diferenças significativas intergrupos (p=0,532)<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>. Embora sem diferenças intergrupos na recorrência de UPD, a termometria mostrou-se viável aos pacientes. </p>
			<p>No maior ECR sobre o tópico até o momento, 44 de 151 (29,1%) que utilizaram a termometria tiveram uma úlcera recorrente em um local primário, o que não foi significativamente diferente dos 57 de 153 (37,3%) participantes do grupo de tratamento usual (RR 0,782; IC 95% 0,566-1,080; p = 0,133). Mas, quando os participantes reduziram sua atividade quando um ponto de inflamação era identificado, a intervenção mostrou-se eficaz sobre os cuidados habituais<xref ref-type="bibr" rid="B31"><sup>31</sup></xref>. </p>
			<p>Em contrapartida, garantir que os pacientes utilizem o termômetro diariamente em âmbito domiciliar e se abstenham de todas as atividades diárias quando a temperatura dos pés estiver elevada, configura-se como um potencial desafio. Ainda, no mundo real, a adesão ao dispositivo por longos períodos, pode ser inferior às registradas neste estudo.</p>
			<p>A sumarização do efeito da intervenção aponta redução do número de úlceras no grupo em uso de termometria cutânea podálica, comparado ao grupo com cuidado padrão (RR=0,53; IC95%, 0,29-0,96; I²=55%; p=0,08). Embora a heterogeneidade estatística seja substancial (I2=55%), deve-se notar que não é estatisticamente significativa. </p>
			<p>O número de pacientes necessários a tratar para evitar o aparecimento de uma nova úlcera cutânea foi de 8. Essa métrica tem sido valiosa na prática clínica, principalmente na seleção de intervenções terapêuticas. Também, tem potencial para uso como uma ferramenta de apoio em avaliações de risco-benefício e em ajudar na tomada de decisões em saúde<xref ref-type="bibr" rid="B33"><sup>33</sup></xref>. Assim, a termometria cutânea representa uma intervenção de fácil aplicação e seu papel preventivo pode contribuir com a redução dos altos custos em saúde e as complicações graves, como hospitalizações, amputações e óbitos. </p>
			<p>A estimativa da eficácia do uso da termometria na prevenção das UPD está apoiada em certeza da evidência moderada. Identificou-se a presença de imprecisão. Recomenda-se rebaixar a certeza da evidência quando o IC sobrepõe a linha de feito nulo ou o número total de eventos seja menor que 300. Deve-se observar que as estimativas dos quatro estudos incluídos favorecem a intervenção e há certa sobreposição dos intervalos de confiança. Neste caso, não se justifica rebaixar a certeza da evidência. Entretanto, o número de eventos está distante do “tamanho ótimo de informação” (<italic>optimal information size</italic>) recomendado<xref ref-type="bibr" rid="B34"><sup>34</sup></xref>. </p>
			<p>Os pontos fortes desta RS incluem a definição explícita dos critérios de inclusão e exclusão dos estudos, uso de uma estratégia de pesquisa abrangente e com alta sensibilidade, triagem rigorosa e aderência à lista de verificação PRISMA, resumo numérico confiável do efeito da intervenção, uso de ferramentas de avaliação da qualidade metodológica e completando com avaliação da certeza da evidência GRADE. Esta busca sistemática e sensível possibilitou agrupamento de intervenções com características semelhantes. </p>
			<p>O tratamento das complicações da úlcera de pé diabético e consequente amputação de membros inferiores é sempre mais caro do que investir em medidas preventivas e abordagem ao pé em risco de ulceração. Por isso, o monitoramento térmico dos pés em pessoas com diabetes tem potencial para contribuir na prática clínica de enfermagem e interprofissional, ao identificar processos ulcerativos iminentes, prevenir novas lesões, evitar amputações de extremidades inferiores e melhorar a qualidade de vida do indivíduo, além de poder reduzir sobrecarga dos serviços de saúde e gastos públicos. </p>
			<p>Nesse contexto, a implementação da avaliação por termometria cutânea no protocolo clínico de exame de indivíduos com diabetes apresenta-se como abordagem potencial, devido sua eficácia na prevenção de ulceração, além de ser técnica não invasiva, necessitar de curto tempo de triagem, sendo sua aplicabilidade viável. Também o automonitoramento diário da temperatura dérmica pelos pacientes ou com ajuda de familiares/cuidadores pode prevenir a ocorrência e recorrência de úlceras de pé diabético.</p>
			<p>As limitações encontradas nesta pesquisa foram que poucos estudos preencheram os critérios de inclusão para esta revisão sistemática. Os autores dessa revisão realizaram contato com os autores dos estudos incluídos via plataforma digital de pesquisadores <ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/">https://www.researchgate.net/</ext-link> para sanar dúvidas, mas não receberam respostas. </p>
			<p>Recomenda-se que pesquisas futuras com amostras maiores sejam realizadas para avaliar o uso desta intervenção. E que também seja avaliado o custo do monitoramento térmico podálico em pessoas com diabetes mellitus, via pesquisas multicêntricas em múltiplos contextos sociais. É relevante considerar se essa intervenção é rentável a uma população mais ampla nos serviços de saúde ou no domicílio. Acredita-se que implementar esta nova abordagem preventiva possa sobressair-se em relação aos altos custos financeiros com complicações das úlceras diabéticas plantares e amputações de extremidades inferiores.</p>
			<p>Novas pesquisas sobre termometria como ferramenta de avaliação térmica dos pés em pessoas com diabetes estão em andamento, sendo possível seu acompanhamento via plataforma <ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov/">https://www.clinicaltrials.gov/</ext-link>.</p>
		</sec>
		<sec sec-type="conclusions">
			<title>Conclusão</title>
			<p>Evidenciou-se que o uso de termômetros infravermelhos para monitoramento da temperatura plantar é ferramenta promissora na prevenção de úlceras podálicas em pessoas com diabetes mellitus. Espera-se que os achados desta revisão sistemática com metanálise sensibilizem e incentivem gestores, serviços públicos de saúde, profissionais de saúde e pacientes/familiares/cuidadores a implementar esta técnica preventiva no contexto clínico e domiciliar, pois a úlcera de pé diabético representa elevado fardo para a saúde pública global.</p>
			<p>A incorporação desta nova abordagem preventiva tem potencial para contribuir na promoção do cuidado interdisciplinar e interprofissional da equipe de saúde, além de promover tomada de decisão clínica, em articulação com as vontades do paciente, melhorar suas condições de saúde e contribuir com a população e gestores, ao permitir planejar, organizar e reforçar novas estratégias preventivas.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>Referências</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. International Working Group on the Diabetic Foot. IWGDF Guidelines on the prevention and management of diabetic foot disease. [Internet]. IWGDF; 2019 [cited 2021 Aug 23]. 194 p. Available from: <ext-link ext-link-type="uri" xlink:href="https://iwgdfguidelines.org/wp-content/uploads/2019/05/IWGDF-Guidelines-2019.pdf">https://iwgdfguidelines.org/wp-content/uploads/2019/05/IWGDF-Guidelines-2019.pdf</ext-link>
				</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<collab>International Working Group on the Diabetic Foot</collab>
					</person-group>
					<source>IWGDF Guidelines on the prevention and management of diabetic foot disease</source>
					<comment>Internet</comment>
					<publisher-name>IWGDF</publisher-name>
					<year>2019</year>
					<date-in-citation content-type="access-date" iso-8601-date="2021-08-23">2021 Aug 23</date-in-citation>
					<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://iwgdfguidelines.org/wp-content/uploads/2019/05/IWGDF-Guidelines-2019.pdf">https://iwgdfguidelines.org/wp-content/uploads/2019/05/IWGDF-Guidelines-2019.pdf</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Selvarajah D, Kar D, Khunti K, Davies MJ, Scott AR, Walker J, et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019 Dec;7(12):938-48. doi: https://doi.org/10.1016/S2213-8587(19)30081-6</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Selvarajah</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Kar</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Khunti</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Davies</surname>
							<given-names>MJ</given-names>
						</name>
						<name>
							<surname>Scott</surname>
							<given-names>AR</given-names>
						</name>
						<name>
							<surname>Walker</surname>
							<given-names>J</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention</article-title>
					<source>Lancet Diabetes Endocrinol</source>
					<year>2019</year>
					<volume>7</volume>
					<issue>12</issue>
					<fpage>938</fpage>
					<lpage>948</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1016/S2213-8587(19)30081-6</pub-id>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. Tchero H, Kangambega P, Lin L, Mukisi-Mukaza M, Brunet-Houdard S, Briatte C, et al. Cost of diabetic foot in France, Spain, Italy, Germany and United Kingdom: A systematic review. Ann Endocrinol (Paris). 2018 Apr;79(2):67-74. doi: https://doi.org/10.1016/j.ando.2017.11.005</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Tchero</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Kangambega</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Lin</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Mukisi-Mukaza</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Brunet-Houdard</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Briatte</surname>
							<given-names>C</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Cost of diabetic foot in France, Spain, Italy, Germany and United Kingdom: A systematic review</article-title>
					<source>Ann Endocrinol (Paris)</source>
					<year>2018</year>
					<volume>79</volume>
					<issue>2</issue>
					<fpage>67</fpage>
					<lpage>74</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1016/j.ando.2017.11.005</pub-id>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Monteiro-Soares M, Russell D, Boyko EJ, Jeffcoate W, Mills JL, Morbach S, et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev. 2020 Mar 16;36(S1). doi: https://doi.org/10.1002/dmrr.3273</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Monteiro-Soares</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Russell</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Boyko</surname>
							<given-names>EJ</given-names>
						</name>
						<name>
							<surname>Jeffcoate</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Mills</surname>
							<given-names>JL</given-names>
						</name>
						<name>
							<surname>Morbach</surname>
							<given-names>S</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Guidelines on the classification of diabetic foot ulcers (IWGDF 2019)</article-title>
					<source>Diabetes Metab Res Rev</source>
					<year>2020</year>
					<volume>36</volume>
					<issue>S1</issue>
					<pub-id pub-id-type="doi">https://doi.org/10.1002/dmrr.3273</pub-id>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Armstrong DG, Lavery LA. Monitoring neuropathic ulcer healing with infrared dermal thermometry. J Foot Ankle Surg. 1996 Jul;35(4):335-8. doi: https://doi.org/10.1016/s1067-2516(96)80083-4</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Armstrong</surname>
							<given-names>DG</given-names>
						</name>
						<name>
							<surname>Lavery</surname>
							<given-names>LA</given-names>
						</name>
					</person-group>
					<article-title>Monitoring neuropathic ulcer healing with infrared dermal thermometry</article-title>
					<source>J Foot Ankle Surg</source>
					<year>1996</year>
					<volume>35</volume>
					<issue>4</issue>
					<fpage>335</fpage>
					<lpage>338</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1016/s1067-2516(96)80083-4</pub-id>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Armstrong DG, Lavery LA, Wunderlich RP, Boulton AJM. Skin Temperatures as a One-time Screening Tool Do Not Predict Future Diabetic Foot Complications. J Am Podiatr Med Assoc. 2003 Nov 1;93(6):443-7. doi: https://doi.org/10.7547/87507315-93-6-443</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Armstrong</surname>
							<given-names>DG</given-names>
						</name>
						<name>
							<surname>Lavery</surname>
							<given-names>LA</given-names>
						</name>
						<name>
							<surname>Wunderlich</surname>
							<given-names>RP</given-names>
						</name>
						<name>
							<surname>Boulton</surname>
							<given-names>AJM</given-names>
						</name>
					</person-group>
					<article-title>Skin Temperatures as a One-time Screening Tool Do Not Predict Future Diabetic Foot Complications</article-title>
					<source>J Am Podiatr Med Assoc</source>
					<year>2003</year>
					<volume>93</volume>
					<issue>6</issue>
					<fpage>443</fpage>
					<lpage>447</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.7547/87507315-93-6-443</pub-id>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. Armstrong DG, Lipsky BA, Polis AB, Abramson MA. Does dermal thermometry predict clinical outcome in diabetic foot infection? Analysis of data from the SIDESTEP trial. Int Wound J. 2006 Dec;3(4):302-7. doi: https://doi.org/10.1111/j.1742-481X.2006.00269.x</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Armstrong</surname>
							<given-names>DG</given-names>
						</name>
						<name>
							<surname>Lipsky</surname>
							<given-names>BA</given-names>
						</name>
						<name>
							<surname>Polis</surname>
							<given-names>AB</given-names>
						</name>
						<name>
							<surname>Abramson</surname>
							<given-names>MA</given-names>
						</name>
					</person-group>
					<article-title>Does dermal thermometry predict clinical outcome in diabetic foot infection? Analysis of data from the SIDESTEP trial</article-title>
					<source>Int Wound J</source>
					<year>2006</year>
					<volume>3</volume>
					<issue>4</issue>
					<fpage>302</fpage>
					<lpage>307</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1111/j.1742-481X.2006.00269.x</pub-id>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Wukich DK, Raspovic KM, Suder NC. Patients With Diabetic Foot Disease Fear Major Lower-Extremity Amputation More Than Death. Foot Ankle Spec. 2018 Feb 1;11(1):17-21. doi: https://doi.org/10.1177/1938640017694722</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wukich</surname>
							<given-names>DK</given-names>
						</name>
						<name>
							<surname>Raspovic</surname>
							<given-names>KM</given-names>
						</name>
						<name>
							<surname>Suder</surname>
							<given-names>NC</given-names>
						</name>
					</person-group>
					<article-title>Patients With Diabetic Foot Disease Fear Major Lower-Extremity Amputation More Than Death</article-title>
					<source>Foot Ankle Spec</source>
					<year>2018</year>
					<volume>11</volume>
					<issue>1</issue>
					<fpage>17</fpage>
					<lpage>21</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1177/1938640017694722</pub-id>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. Martins-Mendes D, Monteiro-Soares M, Boyko EJ, Ribeiro M, Barata P, Lima J, et al. The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk. J Diabetes Complications. 2014 Sep;28(5):632-8. doi: https://doi.org/10.1016/j.jdiacomp.2014.04.011</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Martins-Mendes</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Monteiro-Soares</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Boyko</surname>
							<given-names>EJ</given-names>
						</name>
						<name>
							<surname>Ribeiro</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Barata</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Lima</surname>
							<given-names>J</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk</article-title>
					<source>J Diabetes Complications</source>
					<year>2014</year>
					<volume>28</volume>
					<issue>5</issue>
					<fpage>632</fpage>
					<lpage>638</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1016/j.jdiacomp.2014.04.011</pub-id>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. Sibbald RG, Mufti A, Armstrong DG. Infrared Skin Thermometry. Adv Skin Wound Care. 2015 Jan;28(1):37-44. doi: https://doi.org/10.1097/01.ASW.0000458991.58947.6b</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sibbald</surname>
							<given-names>RG</given-names>
						</name>
						<name>
							<surname>Mufti</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Armstrong</surname>
							<given-names>DG</given-names>
						</name>
					</person-group>
					<article-title>Infrared Skin Thermometry</article-title>
					<source>Adv Skin Wound Care</source>
					<year>2015</year>
					<volume>28</volume>
					<issue>1</issue>
					<fpage>37</fpage>
					<lpage>44</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1097/01.ASW.0000458991.58947.6b</pub-id>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11. Lavery LA, Higgins KR, Lanctot DR, Constantinides GP, Zamorano RG, Armstrong DG, et al. Home Monitoring of Foot Skin Temperatures to Prevent Ulceration. Diabetes Care. 2004 Nov 1;27(11):2642-7. doi: https://doi.org/10.2337/diacare.27.11.2642</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lavery</surname>
							<given-names>LA</given-names>
						</name>
						<name>
							<surname>Higgins</surname>
							<given-names>KR</given-names>
						</name>
						<name>
							<surname>Lanctot</surname>
							<given-names>DR</given-names>
						</name>
						<name>
							<surname>Constantinides</surname>
							<given-names>GP</given-names>
						</name>
						<name>
							<surname>Zamorano</surname>
							<given-names>RG</given-names>
						</name>
						<name>
							<surname>Armstrong</surname>
							<given-names>DG</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Home Monitoring of Foot Skin Temperatures to Prevent Ulceration</article-title>
					<source>Diabetes Care</source>
					<year>2004</year>
					<volume>27</volume>
					<issue>11</issue>
					<fpage>2642</fpage>
					<lpage>2647</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.2337/diacare.27.11.2642</pub-id>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12. Goller H, Lewis DW, Mclaughlin RE. Thermographic studies of human skin subjected to localized pressure. Am J Roentgenol. 1971 Dec;113(4):749-54. doi: https://doi.org/10.2214/ajr.113.4.749</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Goller</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Lewis</surname>
							<given-names>DW</given-names>
						</name>
						<name>
							<surname>Mclaughlin</surname>
							<given-names>RE</given-names>
						</name>
					</person-group>
					<article-title>Thermographic studies of human skin subjected to localized pressure</article-title>
					<source>Am J Roentgenol</source>
					<year>1971</year>
					<volume>113</volume>
					<issue>4</issue>
					<fpage>749</fpage>
					<lpage>754</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.2214/ajr.113.4.749</pub-id>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13. Sandrow RE, Torg JS, Lapayowker MS, Resnick EJ. The Use of Thermography in the Early Diagnosis of Neuropathic Arthropathy in the Feet of Diabetics. Clin Orthop Relat Res. 1972 Oct;88:31-3. doi: https://doi.org/10.1097/00003086-197210000-00004</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sandrow</surname>
							<given-names>RE</given-names>
						</name>
						<name>
							<surname>Torg</surname>
							<given-names>JS</given-names>
						</name>
						<name>
							<surname>Lapayowker</surname>
							<given-names>MS</given-names>
						</name>
						<name>
							<surname>Resnick</surname>
							<given-names>EJ</given-names>
						</name>
					</person-group>
					<article-title>The Use of Thermography in the Early Diagnosis of Neuropathic Arthropathy in the Feet of Diabetics</article-title>
					<source>Clin Orthop Relat Res</source>
					<year>1972</year>
					<volume>88</volume>
					<fpage>31</fpage>
					<lpage>33</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1097/00003086-197210000-00004</pub-id>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14. Stess RM, Sisney PC, Moss KM, Graf PM, Louie KS, Gooding GAW, et al. Use of Liquid Crystal Thermography in the Evaluation of the Diabetic Foot. Diabetes Care. 1986 May 1;9(3):267-72. doi: https://doi.org/10.2337/diacare.9.3.267</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Stess</surname>
							<given-names>RM</given-names>
						</name>
						<name>
							<surname>Sisney</surname>
							<given-names>PC</given-names>
						</name>
						<name>
							<surname>Moss</surname>
							<given-names>KM</given-names>
						</name>
						<name>
							<surname>Graf</surname>
							<given-names>PM</given-names>
						</name>
						<name>
							<surname>Louie</surname>
							<given-names>KS</given-names>
						</name>
						<name>
							<surname>Gooding</surname>
							<given-names>GAW</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Use of Liquid Crystal Thermography in the Evaluation of the Diabetic Foot</article-title>
					<source>Diabetes Care</source>
					<year>1986</year>
					<volume>9</volume>
					<issue>3</issue>
					<fpage>267</fpage>
					<lpage>272</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.2337/diacare.9.3.267</pub-id>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15. Armstrong DG, Lavery LA. Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. J Rehabil Res Dev. 1997 Jul;34(3):317-21. PMID: 9239625.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Armstrong</surname>
							<given-names>DG</given-names>
						</name>
						<name>
							<surname>Lavery</surname>
							<given-names>LA</given-names>
						</name>
					</person-group>
					<article-title>Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry</article-title>
					<source>J Rehabil Res Dev</source>
					<year>1997</year>
					<volume>34</volume>
					<issue>3</issue>
					<fpage>317</fpage>
					<lpage>321</lpage>
					<pub-id pub-id-type="pmid">9239625</pub-id>
				</element-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation>16. Armstrong DG, Holtz-Neiderer K, Wendel C, Mohler MJ, Kimbriel HR, Lavery LA. Skin Temperature Monitoring Reduces the Risk for Diabetic Foot Ulceration in High-risk Patients. Am J Med. 2007 Dec;120(12):104-6. doi: https://doi.org/10.1016/j.amjmed.2007.06.028</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Armstrong</surname>
							<given-names>DG</given-names>
						</name>
						<name>
							<surname>Holtz-Neiderer</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Wendel</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Mohler</surname>
							<given-names>MJ</given-names>
						</name>
						<name>
							<surname>Kimbriel</surname>
							<given-names>HR</given-names>
						</name>
						<name>
							<surname>Lavery</surname>
							<given-names>LA</given-names>
						</name>
					</person-group>
					<article-title>Skin Temperature Monitoring Reduces the Risk for Diabetic Foot Ulceration in High-risk Patients</article-title>
					<source>Am J Med</source>
					<year>2007</year>
					<volume>120</volume>
					<issue>12</issue>
					<fpage>104</fpage>
					<lpage>106</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1016/j.amjmed.2007.06.028</pub-id>
				</element-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation>17. Lavery LA, Higgins KR, Lanctot DR, Constantinides GP, Zamorano RG, Athanasiou KA, et al. Preventing Diabetic Foot Ulcer Recurrence in High-Risk Patients: Use of temperature monitoring as a self-assessment tool. Diabetes Care. 2007 Jan 1;30(1):14-20. doi: https://doi.org/10.2337/dc06-1600</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lavery</surname>
							<given-names>LA</given-names>
						</name>
						<name>
							<surname>Higgins</surname>
							<given-names>KR</given-names>
						</name>
						<name>
							<surname>Lanctot</surname>
							<given-names>DR</given-names>
						</name>
						<name>
							<surname>Constantinides</surname>
							<given-names>GP</given-names>
						</name>
						<name>
							<surname>Zamorano</surname>
							<given-names>RG</given-names>
						</name>
						<name>
							<surname>Athanasiou</surname>
							<given-names>KA</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Preventing Diabetic Foot Ulcer Recurrence in High-Risk Patients: Use of temperature monitoring as a self-assessment tool</article-title>
					<source>Diabetes Care</source>
					<year>2007</year>
					<volume>30</volume>
					<issue>1</issue>
					<fpage>14</fpage>
					<lpage>20</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.2337/dc06-1600</pub-id>
				</element-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation>18. Lazo-Porras M, Bernabe-Ortiz A, Taype-Rondan A, Gilman RH, Malaga G, Manrique H, et al. Foot thermometry with mHeath-based supplementation to prevent diabetic foot ulcers: A randomized controlled trial. Wellcome Open Res. 2020 Aug 28;5:23. doi: https://doi.org/10.12688/wellcomeopenres.15531.2</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lazo-Porras</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Bernabe-Ortiz</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Taype-Rondan</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Gilman</surname>
							<given-names>RH</given-names>
						</name>
						<name>
							<surname>Malaga</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Manrique</surname>
							<given-names>H</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Foot thermometry with mHeath-based supplementation to prevent diabetic foot ulcers: A randomized controlled trial</article-title>
					<source>Wellcome Open Res</source>
					<year>2020</year>
					<volume>5</volume>
					<fpage>23</fpage>
					<lpage>23</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.12688/wellcomeopenres.15531.2</pub-id>
				</element-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation>19. Crawford F, Nicolson DJ, Amanna AE, Martin A, Gupta S, Leese GP, et al. Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data. Diabetologia. 2020 Jan 27;63(1):49-64. doi: https://doi.org/10.1007/s00125-019-05020-7</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Crawford</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Nicolson</surname>
							<given-names>DJ</given-names>
						</name>
						<name>
							<surname>Amanna</surname>
							<given-names>AE</given-names>
						</name>
						<name>
							<surname>Martin</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Gupta</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Leese</surname>
							<given-names>GP</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data</article-title>
					<source>Diabetologia</source>
					<year>2020</year>
					<volume>63</volume>
					<issue>1</issue>
					<fpage>49</fpage>
					<lpage>64</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1007/s00125-019-05020-7</pub-id>
				</element-citation>
			</ref>
			<ref id="B20">
				<label>20</label>
				<mixed-citation>20. Ena J, Carretero-Gomez J, Arevalo-Lorido JC, Sanchez-Ardila C, Zapatero-Gaviria A, Gómez-Huelgas R. The Association Between Elevated Foot Skin Temperature and the Incidence of Diabetic Foot Ulcers: A Meta-Analysis. Int J Low Extrem Wounds. 2021 Jun 28;20(2):111-8. doi: https://doi.org/10.1177/1534734619897501</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ena</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Carretero-Gomez</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Arevalo-Lorido</surname>
							<given-names>JC</given-names>
						</name>
						<name>
							<surname>Sanchez-Ardila</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Zapatero-Gaviria</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Gómez-Huelgas</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>The Association Between Elevated Foot Skin Temperature and the Incidence of Diabetic Foot Ulcers: A Meta-Analysis</article-title>
					<source>Int J Low Extrem Wounds</source>
					<year>2021</year>
					<volume>20</volume>
					<issue>2</issue>
					<fpage>111</fpage>
					<lpage>118</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1177/1534734619897501</pub-id>
				</element-citation>
			</ref>
			<ref id="B21">
				<label>21</label>
				<mixed-citation>21. Alahakoon C, Fernando M, Galappaththy C, Matthews EO, Lazzarini P, Moxon JV, et al. Meta-analyses of randomized controlled trials reporting the effect of home foot temperature monitoring, patient education or offloading footwear on the incidence of diabetes-related foot ulcers. Diabet Med. 2020 Aug 8;37(8):1266-79. doi: https://doi.org/10.1111/dme.14323</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Alahakoon</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Fernando</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Galappaththy</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Matthews</surname>
							<given-names>EO</given-names>
						</name>
						<name>
							<surname>Lazzarini</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Moxon</surname>
							<given-names>JV</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Meta-analyses of randomized controlled trials reporting the effect of home foot temperature monitoring, patient education or offloading footwear on the incidence of diabetes-related foot ulcers</article-title>
					<source>Diabet Med</source>
					<year>2020</year>
					<volume>37</volume>
					<issue>8</issue>
					<fpage>1266</fpage>
					<lpage>1279</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1111/dme.14323</pub-id>
				</element-citation>
			</ref>
			<ref id="B22">
				<label>22</label>
				<mixed-citation>22. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;n71. doi: http://doi.org/10.1136/bmj.n71</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Page</surname>
							<given-names>MJ</given-names>
						</name>
						<name>
							<surname>McKenzie</surname>
							<given-names>JE</given-names>
						</name>
						<name>
							<surname>Bossuyt</surname>
							<given-names>PM</given-names>
						</name>
						<name>
							<surname>Boutron</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Hoffmann</surname>
							<given-names>TC</given-names>
						</name>
						<name>
							<surname>Mulrow</surname>
							<given-names>CD</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title>
					<source>BMJ</source>
					<year>2021</year>
					<volume>n71</volume>
					<pub-id pub-id-type="doi">http://doi.org/10.1136/bmj.n71</pub-id>
				</element-citation>
			</ref>
			<ref id="B23">
				<label>23</label>
				<mixed-citation>23. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021) [Internet]. London: Cochrane; 2021 [cited 2021 Aug 23]. Available from: <ext-link ext-link-type="uri" xlink:href="https://training.cochrane.org/handbook/current">https://training.cochrane.org/handbook/current</ext-link>
				</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Higgins</surname>
							<given-names>JPT</given-names>
						</name>
						<name>
							<surname>Thomas</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Chandler</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Cumpston</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Li</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Page</surname>
							<given-names>MJ</given-names>
						</name>
					</person-group>
					<source>Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021)</source>
					<year>2021</year>
					<publisher-loc>London</publisher-loc>
					<publisher-name>Cochrane</publisher-name>
					<ext-link ext-link-type="uri" xlink:href="https://training.cochrane.org/handbook/current">https://training.cochrane.org/handbook/current</ext-link>
				</element-citation>
			</ref>
			<ref id="B24">
				<label>24</label>
				<mixed-citation>24. Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007 Dec 15;7(1):16. doi: https://doi.org/10.1186/1472-6947-7-16</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Schardt</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Adams</surname>
							<given-names>MB</given-names>
						</name>
						<name>
							<surname>Owens</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Keitz</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Fontelo</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Utilization of the PICO framework to improve searching PubMed for clinical questions</article-title>
					<source>BMC Med Inform Decis Mak</source>
					<year>2007</year>
					<volume>7</volume>
					<issue>1</issue>
					<fpage>16</fpage>
					<lpage>16</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1186/1472-6947-7-16</pub-id>
				</element-citation>
			</ref>
			<ref id="B25">
				<label>25</label>
				<mixed-citation>25. Siddaway AP, Wood AM, Hedges LV. How to Do a Systematic Review: A Best Practice Guide for Conducting and Reporting Narrative Reviews, Meta-Analyses, and Meta-Syntheses. Annu Rev Psychol. 2019 Jan 4;70(1):747-70. doi: https://doi.org/10.1146/annurev-psych-010418-102803</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Siddaway</surname>
							<given-names>AP</given-names>
						</name>
						<name>
							<surname>Wood</surname>
							<given-names>AM</given-names>
						</name>
						<name>
							<surname>Hedges</surname>
							<given-names>LV</given-names>
						</name>
					</person-group>
					<article-title>How to Do a Systematic Review: A Best Practice Guide for Conducting and Reporting Narrative Reviews, Meta-Analyses, and Meta-Syntheses</article-title>
					<source>Annu Rev Psychol</source>
					<year>2019</year>
					<volume>70</volume>
					<issue>1</issue>
					<fpage>747</fpage>
					<lpage>770</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1146/annurev-psych-010418-102803</pub-id>
				</element-citation>
			</ref>
			<ref id="B26">
				<label>26</label>
				<mixed-citation>26. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016 Dec 5;5(1):210. doi: https://doi.org/10.1186/s13643-016-0384-4</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ouzzani</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Hammady</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Fedorowicz</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Elmagarmid</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Rayyan-a web and mobile app for systematic reviews</article-title>
					<source>Syst Rev</source>
					<year>2016</year>
					<volume>5</volume>
					<issue>1</issue>
					<fpage>210</fpage>
					<lpage>210</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1186/s13643-016-0384-4</pub-id>
				</element-citation>
			</ref>
			<ref id="B27">
				<label>27</label>
				<mixed-citation>27. Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019 Aug 28;4898. doi: https://doi.org/10.1136/bmj.l4898</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sterne</surname>
							<given-names>JAC</given-names>
						</name>
						<name>
							<surname>Savovic</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Page</surname>
							<given-names>MJ</given-names>
						</name>
						<name>
							<surname>Elbers</surname>
							<given-names>RG</given-names>
						</name>
						<name>
							<surname>Blencowe</surname>
							<given-names>NS</given-names>
						</name>
						<name>
							<surname>Boutron</surname>
							<given-names>I</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>RoB 2: a revised tool for assessing risk of bias in randomised trials</article-title>
					<source>BMJ</source>
					<year>2019</year>
					<issue>4898</issue>
					<pub-id pub-id-type="doi">https://doi.org/10.1136/bmj.l4898</pub-id>
				</element-citation>
			</ref>
			<ref id="B28">
				<label>28</label>
				<mixed-citation>28. The Cochrane Collaboration. Review Manager (RevMan) [Computer program]. Version 5.4. London: The Cochrane Collaboration; 2020 [cited 2021 Aug 23]. Available from: <ext-link ext-link-type="uri" xlink:href="https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman">https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman</ext-link>
				</mixed-citation>
				<element-citation publication-type="software">
					<person-group person-group-type="author">
						<collab>The Cochrane Collaboration</collab>
					</person-group>
					<source>Review Manager (RevMan)</source>
					<year>2020</year>
					<publisher-loc>London</publisher-loc>
					<publisher-name>The Cochrane Collaboration</publisher-name>
					<comment>Computer program</comment>
					<version>5.4</version>
					<date-in-citation content-type="access-date" iso-8601-date="2021-08-23">2021 Aug 23</date-in-citation>
					<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman">https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B29">
				<label>29</label>
				<mixed-citation>29. Higgins JPT. Measuring inconsistency in meta-analyses. BMJ. 2003 Sep 6;327(7414):557-60. doi: https://doi.org/10.1136/bmj.327.7414.557</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Higgins</surname>
							<given-names>JPT</given-names>
						</name>
					</person-group>
					<article-title>Measuring inconsistency in meta-analyses</article-title>
					<source>BMJ</source>
					<year>2003</year>
					<volume>327</volume>
					<issue>7414</issue>
					<fpage>557</fpage>
					<lpage>560</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1136/bmj.327.7414.557</pub-id>
				</element-citation>
			</ref>
			<ref id="B30">
				<label>30</label>
				<mixed-citation>30. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008 Apr 26;336(7650):924-6. doi: https://doi.org/10.1136/bmj.39489.470347.AD</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Guyatt</surname>
							<given-names>GH</given-names>
						</name>
						<name>
							<surname>Oxman</surname>
							<given-names>AD</given-names>
						</name>
						<name>
							<surname>Vist</surname>
							<given-names>GE</given-names>
						</name>
						<name>
							<surname>Kunz</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Falck-Ytter</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Alonso-Coello</surname>
							<given-names>P</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>GRADE: an emerging consensus on rating quality of evidence and strength of recommendations</article-title>
					<source>BMJ</source>
					<year>2008</year>
					<volume>336</volume>
					<issue>7650</issue>
					<fpage>924</fpage>
					<lpage>926</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1136/bmj.39489.470347.AD</pub-id>
				</element-citation>
			</ref>
			<ref id="B31">
				<label>31</label>
				<mixed-citation>31. Bus SA, Stegge WB, Baal JG, Busch-Westbroek TE, Nollet F, Netten JJ. Effectiveness of at-home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP). BMJ Open Diabetes Res Care. 2021 Sep;9(1):e002392. doi: https://doi.org/10.1136/bmjdrc-2021-002392</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Bus</surname>
							<given-names>SA</given-names>
						</name>
						<name>
							<surname>Stegge</surname>
							<given-names>WB</given-names>
						</name>
						<name>
							<surname>Baal</surname>
							<given-names>JG</given-names>
						</name>
						<name>
							<surname>Busch-Westbroek</surname>
							<given-names>TE</given-names>
						</name>
						<name>
							<surname>Nollet</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Netten</surname>
							<given-names>JJ</given-names>
						</name>
					</person-group>
					<article-title>Effectiveness of at-home skin temperature monitoring in reducing the incidence of foot ulcer recurrence in people with diabetes: a multicenter randomized controlled trial (DIATEMP)</article-title>
					<source>BMJ Open Diabetes Res Care</source>
					<year>2021</year>
					<volume>9</volume>
					<issue>1</issue>
					<elocation-id>e002392</elocation-id>
					<pub-id pub-id-type="doi">https://doi.org/10.1136/bmjdrc-2021-002392</pub-id>
				</element-citation>
			</ref>
			<ref id="B32">
				<label>32</label>
				<mixed-citation>32. Skafjeld A, Iversen MM, Holme I, Ribu L, Hvaal K, Kilhovd BK. A pilot study testing the feasibility of skin temperature monitoring to reduce recurrent foot ulcers in patients with diabetes - a randomized controlled trial. BMC Endocr Disord. 2015 Dec 9;15(1):55. doi: https://doi.org/10.1186/s12902-015-0054-x</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Skafjeld</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Iversen</surname>
							<given-names>MM</given-names>
						</name>
						<name>
							<surname>Holme</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Ribu</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Hvaal</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Kilhovd</surname>
							<given-names>BK</given-names>
						</name>
					</person-group>
					<article-title>A pilot study testing the feasibility of skin temperature monitoring to reduce recurrent foot ulcers in patients with diabetes - a randomized controlled trial</article-title>
					<source>BMC Endocr Disord</source>
					<year>2015</year>
					<volume>15</volume>
					<issue>1</issue>
					<fpage>55</fpage>
					<lpage>55</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1186/s12902-015-0054-x</pub-id>
				</element-citation>
			</ref>
			<ref id="B33">
				<label>33</label>
				<mixed-citation>33. Mendes D, Alves C, Batel-Marques F. Number needed to treat (NNT) in clinical literature: an appraisal. BMC Med. 2017 Dec 1;15(1):112. doi: https://doi.org/10.1186/s12916-017-0875-8</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mendes</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Alves</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Batel-Marques</surname>
							<given-names>F</given-names>
						</name>
					</person-group>
					<article-title>Number needed to treat (NNT) in clinical literature an appraisal</article-title>
					<source>BMC Med</source>
					<year>2017</year>
					<volume>15</volume>
					<issue>1</issue>
					<fpage>112</fpage>
					<lpage>112</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1186/s12916-017-0875-8</pub-id>
				</element-citation>
			</ref>
			<ref id="B34">
				<label>34</label>
				<mixed-citation>34. Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol. 2011 Dec;64(12):1283-93. doi: https://doi.org/10.1016/j.jclinepi.2011.01.012</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Guyatt</surname>
							<given-names>GH</given-names>
						</name>
						<name>
							<surname>Oxman</surname>
							<given-names>AD</given-names>
						</name>
						<name>
							<surname>Kunz</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Brozek</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Alonso-Coello</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Rind</surname>
							<given-names>D</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>GRADE guidelines 6 Rating the quality of evidence-imprecision</article-title>
					<source>J Clin Epidemiol</source>
					<year>2011</year>
					<volume>64</volume>
					<issue>12</issue>
					<fpage>1283</fpage>
					<lpage>1293</lpage>
					<pub-id pub-id-type="doi">https://doi.org/10.1016/j.jclinepi.2011.01.012</pub-id>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="presented-at" id="fn2">
				<p>Artigo extraído da dissertação de mestrado “Efeito da termometria na prevenção de úlceras podálicas em pessoas com diabetes mellitus: revisão sistemática com metanálise”, apresentada à Universidade Estadual do Ceará, Fortaleza, CE, Brasil. O presente trabalho foi realizado com apoio da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) - Código de Financiamento 001, Brasil.</p>
			</fn>
			<fn fn-type="other">
				<label>Errata</label>
				<p>Na página 1, onde se lia:</p>
				<p>“Artigo Original”</p>
				<p>Leia-se:</p>
				<p>“Artigo de Revisão”</p>
			</fn>
		</fn-group>
	</back>
	<sub-article article-type="translation" id="s1" xml:lang="en">
		<front-stub>
			<article-id pub-id-type="doi">10.1590/1518-8345.5663.3525</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Review Article</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Effect of thermometry on the prevention of diabetic foot ulcers: *</article-title>
				<subtitle>a systematic review with meta-analysis</subtitle>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-0100-0147</contrib-id>
					<name>
						<surname>Araújo</surname>
						<given-names>Açucena Leal de</given-names>
					</name>
					<xref ref-type="aff" rid="aff6"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff7"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-3150-2540</contrib-id>
					<name>
						<surname>Negreiros</surname>
						<given-names>Francisca Diana da Silva</given-names>
					</name>
					<xref ref-type="aff" rid="aff8"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-3119-7187</contrib-id>
					<name>
						<surname>Florêncio</surname>
						<given-names>Raquel Sampaio</given-names>
					</name>
					<xref ref-type="aff" rid="aff6"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff7"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-3902-8046</contrib-id>
					<name>
						<surname>Oliveira</surname>
						<given-names>Shérida Karanini Paz de</given-names>
					</name>
					<xref ref-type="aff" rid="aff6"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-5087-4310</contrib-id>
					<name>
						<surname>Silva</surname>
						<given-names>Ana Roberta Vilarouca da</given-names>
					</name>
					<xref ref-type="aff" rid="aff9"><sup>4</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-1424-0649</contrib-id>
					<name>
						<surname>Moreira</surname>
						<given-names>Thereza Maria Magalhães</given-names>
					</name>
					<xref ref-type="aff" rid="aff6"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff10"><sup>5</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff6">
				<label>1</label>
				<institution content-type="original"> Universidade Estadual do Ceará, Fortaleza, CE, Brazil.</institution>
			</aff>
			<aff id="aff7">
				<label>2</label>
				<institution content-type="original"> Bolsista da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil.</institution>
			</aff>
			<aff id="aff8">
				<label>3</label>
				<institution content-type="original"> Universidade Federal do Ceará, Fortaleza, CE, Brazil.</institution>
			</aff>
			<aff id="aff9">
				<label>4 </label>
				<institution content-type="original">Universidade Federal do Piauí, Picos, PI, Brazil.</institution>
			</aff>
			<aff id="aff10">
				<label>5</label>
				<institution content-type="original"> Bolsista do Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil.</institution>
			</aff>
			<author-notes>
				<corresp id="c2">
					<label>Corresponding author:</label> Açucena Leal de Araújo. E-mail: <email>a.leal09@hotmail.com</email>
				</corresp>
				<fn fn-type="edited-by" id="fn5">
					<label>Associate Editor</label>
					<p> Maria Lúcia Zanetti.</p>
				</fn>
				<fn fn-type="con" id="fn7">
					<label>Authors’ contribution</label>
					<p><bold>Study concept and design:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Thereza Maria Magalhães Moreira. <bold>Obtaining data:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Raquel Sampaio Florêncio, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva. <bold>Data analysis and interpretation:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Raquel Sampaio Florêncio, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva, Thereza Maria Magalhães Moreira. <bold>Statistical analysis:</bold> Açucena Leal de Araújo, Raquel Sampaio Florêncio, Thereza Maria Magalhães Moreira. <bold>Drafting the manuscript:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva, Thereza Maria Magalhães Moreira. <bold>Critical review of the manuscript as to its relevant intellectual content:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Raquel Sampaio Florêncio, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva, Thereza Maria Magalhães Moreira. All authors approved the final version of the text.</p>
				</fn>
				<fn fn-type="conflict" id="fn8">
					<label>Conflict of interest</label>
					<p> The authors have declared that there is no conflict of interest.</p>
				</fn>
			</author-notes>
			<abstract>
				<title>Abstract</title>
				<sec>
					<title>Objective:</title>
					<p> to analyze the effect of cutaneous foot thermometry in people with Diabetes Mellitus, compared with the standard prevention of foot ulcers adopted in these patients. </p>
				</sec>
				<sec>
					<title>Method:</title>
					<p> a systematic review with meta-analysis. Protocol registered with PROSPERO (CRD42020202686). The recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) were followed. The search was performed in the following data sources: SCOPUS, Web of Science, MEDLINE via PubMed, MEDLINE via EBSCO, MEDLINE via <italic>Biblioteca Virtual em Saúde</italic>, Embase, CINAHL, Cochrane Library, LILACS via <italic>Biblioteca Virtual em Saúde</italic>, Google Scholar, <italic>Biblioteca Digital Brasileira de Teses e Dissertações, Catálogo de Teses &amp; Dissertações-Capes</italic>, Open Grey and ProQuest Dissertations and Theses. The risk of bias was assessed by the Cochrane Collaboration Risk of Bias Tool (RoB 2), the meta-analysis was performed in the Review Manager 5.4 software and the Certainty of evidence in the Grading of Recommendations Assessment, Development and Evaluation system. </p>
				</sec>
				<sec>
					<title>Results:</title>
					<p> of the 670 records, five articles were eligible. The meta-analysis was calculated for the prevention of the incidence of diabetic foot ulcers outcome, with effect summarization (RR 0.53; 95%CI 0.29-0.96; p=0.02), with certainty of moderate evidence. </p>
				</sec>
				<sec>
					<title>Conclusion:</title>
					<p> thermometry showed a protective effect on the incidence of diabetic foot ulcers when compared to standard foot care.</p>
				</sec>
			</abstract>
			<kwd-group xml:lang="en">
				<title>Descriptors:</title>
				<kwd>Diabetes Mellitus</kwd>
				<kwd>Thermometry</kwd>
				<kwd>Diabetic Foot</kwd>
				<kwd>Prevention</kwd>
				<kwd>Nursing</kwd>
				<kwd>Systematic Review</kwd>
			</kwd-group>
		</front-stub>
		<body>
			<boxed-text id="bx2">
				<sec>
					<title>Highlights</title>
					<p>(1) Diabetic foot ulcers are preceded by an increase in local dermal temperature.</p>
					<p>(2) Thermometry can assist in the early identification of inflammation/ulceration.</p>
					<p>(3) Temperature measurements can be easily taken by the patients/family members.</p>
					<p>(4) Thermometry can contribute to reducing the burden on the health services.</p>
					<p>(5) The efficacy of thermometry is supported by the certainty of moderate evidence.</p>
				</sec>
			</boxed-text>
			<sec sec-type="intro">
				<title>Introduction</title>
				<p>The current approaches adopted by health services in the prevention and early treatment of Diabetic Foot Ulcers (DFUs) are multiple and varied. Screening and education in health for the patient, family and health professionals are relevant pillars<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>. However, efforts to prevent DFU remain a challenge and demand high costs for global public health<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref>, raising the need for new preventive approaches.</p>
				<p>DFUs are preceded by an increase in local dermal temperature by inflammation and enzymatic tissue autolysis resulting from pressure-activity imbalance, added to repetitive stress, neuropathic sensory loss and biomechanical abnormalities<xref ref-type="bibr" rid="B4"><sup>4</sup></xref>. A temperature difference of 2.2ºC between the same site on both feet implies a risk for imminent ulcer/inflammation<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>. However, clinical signs of inflammation are subtle for detection by patients or even by trained health professionals<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>. Although many signs of inflammation are difficult to be objectively assessed, temperature can be easily measured. </p>
				<p>The traditional method of assessing foot temperature is palpation with the back of the hand. However, with this method, humans are only able to discriminate temperature differences greater than 2ºC. Thus, skin thermometry emerges as a promising tool for identifying inflammation, providing early signs to prevent DFU incidence and reduce serious complications, such as high morbidity, frequent hospitalizations, lower limb amputation and deaths<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref>. It is the method most used by the scientific community and patients, as it involves the use of a thermometer, a low-cost and easy to apply instrument<xref ref-type="bibr" rid="B10"><sup>10</sup></xref>. As a result, the patients can modify their activity, measuring skin temperature, as well as dosing their insulin and checking their blood glucose<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>.</p>
				<p>A study reported an association between increased local temperature and localized pressure, causing tissue damage<xref ref-type="bibr" rid="B12"><sup>12</sup></xref>. A number of researchers used thermometry as a tool to diagnose occult neuropathic fractures in patients with diabetes<xref ref-type="bibr" rid="B13"><sup>13</sup></xref>. Temperature assessment is a useful technique to identify patients at risk for ulceration<xref ref-type="bibr" rid="B14"><sup>14</sup></xref>. Similar findings were identified with a handheld infrared thermometer in patients with asymptomatic sensory neuropathy, neuropathic foot ulcers and patients with neuropathic fractures (Charcot arthropathy)<xref ref-type="bibr" rid="B15"><sup>15</sup></xref>.</p>
				<p>Foot temperature varies with the patient’s activity level and environment. The reference is a corresponding area on the contralateral foot. It is noteworthy that the temperatures of these areas do not differ by more than 1ºC<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref> and a number of studies suggest that differences ≥ 2.2ºC in temperature can be considered a risk for ulceration<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref>.</p>
				<p><italic>Worldwide, three Randomized Controlled Clinical Trials (RCTs) tested self-monitoring of foot skin temperature in people with Diabetes Mellitus and their risk for ulceration, via skin infrared thermometry as a warning sign of impending ulcer. These studies showed a significant reduction in the incidence of new foot ulcers</italic><xref ref-type="bibr" rid="B11"><sup><italic>11</italic></sup></xref><sup><italic>,</italic></sup><xref ref-type="bibr" rid="B16"><sup><italic>16</italic></sup></xref><sup><italic>-</italic></sup><xref ref-type="bibr" rid="B17"><sup><italic>17</italic></sup></xref><italic>.</italic></p>
				<p>Previous systematic reviews have analyzed the effect of several interventions to prevent diabetic foot ulcers, including the use of thermal foot monitoring<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref>. Although reviews on the subject matter were identified, failures to provide reliable numerical summaries of effects were observed due to limitations in the quality of the individual studies. In addition to that, new evidence has emerged since then. Thus, a comprehensive evaluation of randomized controlled trials was necessary to allow us to make the best use of the currently available evidence.</p>
				<p>This systematic review with meta-analysis aimed at analyzing the effect of cutaneous foot thermometry in people with Diabetes Mellitus (DM), when compared to the standard prevention of foot ulcers adopted in these patients.</p>
			</sec>
			<sec sec-type="methods">
				<title>Method</title>
				<sec>
					<title>Protocol and registration</title>
					<p>This is a systematic literature review, according to the criteria of the <italic>Prefe</italic>rred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. This type of study summarizes diverse evidence from primary studies conducted to answer a specific research question. It uses a comprehensive, impartial and reproducible literature review process, and locates, evaluates and synthesizes the set of evidence from the scientific studies to obtain an overview and reliable estimate of the intervention’s effect<xref ref-type="bibr" rid="B23"><sup>23</sup></xref>.</p>
					<p>This review had its protocol previously published on York University’s International Prospective Register of Systematic Reviews (PROSPERO) platform, with registration number CRD42020202686, obtained on September 4<sup>th</sup>, 2020.</p>
				</sec>
				<sec>
					<title>Research question and eligibility criteria</title>
					<p>The Population, Intervention, Control and Outcome (PICO) strategy was used for data research<xref ref-type="bibr" rid="B24"><sup>24</sup></xref>. This systematic review with meta-analysis focused on participants (P) diagnosed with Diabetes Mellitus, with or without risk of developing diabetic foot ulcer. The use of cutaneous thermometry devices to assess foot temperature was arranged as an intervention (I). The use of standard foot care (therapeutic footwear, diabetic foot education, regular foot assessment by health professionals, and foot self-care) was provided as a comparison (C). And the outcomes (O) evaluated were studies that included the prevention of the incidence of diabetic foot ulcers outcome. </p>
					<p>From this, the research problem was outlined: Which is the effect of cutaneous foot thermometry on people with DM, when compared to the standard prevention of foot ulcers adopted in these patients?</p>
					<p>The studies were included when they met the following criteria: DM diagnosis, age ≥ 18 years old, clinical trial with intervention group with thermometry in the prevention of Diabetic Foot Ulcers (DFUs) and control group with standard health care. No restrictions were adopted regarding language and year of publication, nor in relation to the risk for DFU (according to the stratification of the International Working Group on Diabetic Foot)<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>. We discarded publications with: study intervention with foot skin thermometry in people with and without DM; thermometry in people with simultaneous Diabetes Mellitus and active ulcer; study designs: cross-sectional, prospective and retrospective cohort, case-control, case reports or case series; types of publication: reviews, protocols, letters to the editor, congress abstracts, personal opinions, book chapters; unavailable in full.</p>
				</sec>
				<sec>
					<title>Search in data sources</title>
					<p>The search was performed in the gray literature and in the databases on July 26<sup>th</sup>, 2020, without language or year restrictions. An update of the searches in the data sources was performed on November 21<sup>st</sup>, 2021. A librarian familiar with the health sciences was consulted when developing and conducting the research. </p>
					<p>The databases used were the following: SCOPUS, Web of Science, MEDLINE (Medical Literature Analysis and Retrieval System Online) via PubMed, MEDLINE (Medical Literature Analysis and Retrieval System Online) via EBSCO, MEDLINE (Medical Literature Analysis and Retrieval System Online) via <italic>Biblioteca Virtual em Saúde</italic> (BVS), Embase, CINAHL (Cumulative Index to Nursing and Allied Health Literature), Cochrane Library (The Cochrane Central Register of Controlled Trials - CENTRAL) and LILACS (<italic>Literatura Latino-Americana e do Caribe em Ciências da Saúde</italic>) via <italic>Biblioteca Virtual em Saúde</italic> (BVS). </p>
					<p>In order to reduce publication bias and identify as much relevant evidence as possible, the following gray literature databases were also consulted: Google Scholar, <italic>Biblioteca Digital Brasileira de Teses e Dissertações</italic> (BDTD), <italic>Catálogo de Teses &amp; Dissertações</italic> - CAPES, Open Grey and ProQuest Dissertations and Theses (PQDT). </p>
					<p>Additionally, another search for the references of the studies included was necessary. An additional search was also carried out in consultation with “experts/specialists” in the researched area via <ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/">https://www.researchgate.net/</ext-link>. They were invited to suggest relevant articles on the chosen topic. However, no answers were obtained.</p>
				</sec>
				<sec>
					<title>Search strategy</title>
					<p>The search strategy was built using three controlled health vocabularies: Medical Subject Headings (MeSH), <italic>Descritores em Ciências da Saúde</italic> (DeCS) and EMTREE; together with natural language, in order to obtain a wide spectrum of results in different databases<xref ref-type="bibr" rid="B25"><sup>25</sup></xref>. After the search terms have been defined, they were combined with the Boolean operators AND and OR. </p>
					<p>The following high-sensitivity search strategy was used for all databases: (“diabetes mellitus” OR “diabetic patient” OR diabetes OR diabetic) AND (“temperature measurement” OR “temperature monitoring” OR “temperature recording” OR “thermal measurement” OR “thermal monitoring” OR “thermal recording” OR “thermo-monitoring” OR “thermo-recording” OR “body temperature monitoring” OR thermometer OR thermometry OR thermogram OR thermomonitoring OR thermorecording OR thermomeasurement) AND (prevention OR prevent OR control OR prophylaxis OR “prevent ulceration” OR “ulcer prevention” OR “prophylactic treatment” OR “preventive therapy” OR “preventive measures” OR “disease prevention” OR “disease prophylaxis” OR “health protection” OR “preventive treatment” OR “prophylactic management” OR “prophylactic therapy” OR “prophylactic treatment”) AND (foot OR ulcer OR ulceration OR feet OR “foot ulceration” OR “foot ulcer” OR “foot complication” OR “diabetic foot” OR “diabetic feet”).</p>
				</sec>
				<sec>
					<title>Selection of the studies and extraction of the information</title>
					<p>The research results in each database were imported into the Rayyan<sup>®</sup> reference manager developed by the Qatar Computing Research Institute (QCRI), for organization of the studies, removal of duplicates, and selection and screening of the studies<xref ref-type="bibr" rid="B26"><sup>26</sup></xref>. Two authors of the review independently examined the titles and abstracts of all references. Subsequently, the full texts of potentially eligible studies were independently assessed by the two reviewers to determine whether all inclusion criteria were met. In case of disagreements, the third author of the review was consulted.</p>
					<p>The data from the studies selected for the final sample were independently extracted by the two reviewers and then compared. A standardized clinical form created in <italic>Microsoft Excel</italic><sup>®</sup> was used and, finally, the data collected were compiled into a table. The data collected were the following: study characteristics (author, year, country, objective); population characteristics (total sample, gender, type of diabetes and mean age), characteristics of the intervention and control groups (place of sample recruitment, duration in months, number of participants in each group, description of the intervention and of the control), characteristics of the result (outcomes evaluated, main outcomes) and conclusion. Afterwards, the results of collection were compared, discussing what was really relevant with the third reviewer. If there was information that was lacking, ambiguous, incomplete or not described in the primary studies, efforts were made to contact the authors.</p>
					<p>The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart was used to document selection of the studies.</p>
				</sec>
				<sec>
					<title>Risk of bias analysis in the individual studies</title>
					<p>The risk of bias assessment of the studies included was analyzed using the Cochrane Collaboration Risk of Bias Tool (RoB 2) for randomized studies<xref ref-type="bibr" rid="B27"><sup>27</sup></xref>. RoB 2 includes judgments about random sequence generation, allocation concealment, participant and staff blinding, results evaluator blinding, incomplete results data, selective reporting, and other sources of bias. The studies were categorized into groups labeled as low risk of bias, uncertain risk of bias, or high risk of bias.</p>
					<p>RoB 2 has the novelty of considering that it is not always possible to blind the participants. We should only lower the quality of the evidence if lack of blinding affects the interventions in an unbalanced way between the groups and if it affects outcomes<xref ref-type="bibr" rid="B27"><sup>27</sup></xref>. Risk of bias was performed by two independent reviewers. In case of disagreements in the judgment of the two reviewers, an evaluation by the third reviewer was requested.</p>
					<p>To summarize the risk of bias analysis, the Cochrane Collaborations’s Review Manager 5 (RevMan 5.4) tool was used and allowed for the elaboration of the risk of bias summary<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. </p>
				</sec>
				<sec>
					<title>Data synthesis</title>
					<p>A descriptive synthesis of the characteristics of the studies was carried out. The quantitative synthesis of the data was performed in a meta-analysis of studies considered combinable and homogeneous in relation to interventions and results. Cochrane Collaboration’s Review Manager<sup>®</sup>5 (RevMan 5.4)<xref ref-type="bibr" rid="B28"><sup>28</sup></xref> was used to perform the meta-analysis, presented using a forest plot graph. The heterogeneity present in the studies was evaluated by the I2 statistical test of inconsistency indices, considering values of 0-30% for unimportant heterogeneity, 31-50% for moderate heterogeneity, 51-80% for substantial heterogeneity and 81-100% for considerable heterogeneity<xref ref-type="bibr" rid="B29"><sup>29</sup></xref>. The results were presented with 95% Confidence Intervals (95%CI).</p>
					<p>The random effect model was chosen<xref ref-type="bibr" rid="B29"><sup>29</sup></xref> to perform the meta-analysis. As a measure of effect, for binary outcomes (the result can be 1 of 2 possibilities) the Risk Ratio (RR, or relative risk) was used, considering in this study the occurrence or not of diabetic foot ulcer. As for the estimate of the effect of the individual studies, this was calculated using the Mantel-Haenszel statistical method, ideal for studies with small sample sizes.</p>
				</sec>
				<sec>
					<title>Evidence certainty classification</title>
					<p>This research used Cochrane’s Grading of Recommendations Assessment, Development and Evaluation (GRADE) system to classify the certainty of the evidence<xref ref-type="bibr" rid="B30"><sup>30</sup></xref>. The criteria evaluated were study design, risk of bias, inconsistency, indirect evidence, imprecision, and other considerations. The certainty of the evidence can be characterized as high, moderate, low or very low. The construction of a funnel chart to assess the presence of publication bias was waived because the few randomized clinical trials were less than ten. </p>
					<p>A table called “GRADE Evidence Profile” was created to summarize the findings of this evaluation. In this process, the GRADEpro GDT (Guideline Development Tool) online tool was used, which is freely accessible from <ext-link ext-link-type="uri" xlink:href="http://www.gradepro.org">http://www.gradepro.org</ext-link>.</p>
				</sec>
			</sec>
			<sec sec-type="results">
				<title>Results</title>
				<sec>
					<title>Characteristics of the studies included</title>
					<p>A total of 670 records were identified. After removing the duplicates, 373 were left for screening. After the titles and abstracts have been screened, 326 records were excluded for not meeting the inclusion criteria, leaving 47 potentially relevant studies. Of these, 4 records were not retrieved in full, leaving 43 for full-text screening. After full-reading, 38 did not meet the eligibility criteria, leaving 5 studies (<xref ref-type="fig" rid="f4">Figure 1</xref>). </p>
					<p>
						<fig id="f4">
							<label>Figure 1</label>
							<caption>
								<title>Search flowchart according to the PRISMA recommendations<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>
								</title>
							</caption>
							<graphic xlink:href="1518-8345-rlae-30-e3567-gf4.png"/>
						</fig>
					</p>
					<p>The final result were five Randomized Clinical Trials (RCTs), with a total of 828 participants, conducted in the United States<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>, Holland<xref ref-type="bibr" rid="B31"><sup>31</sup></xref> and Norway<xref ref-type="bibr" rid="B32"><sup>32</sup></xref> and published in English between 2004 and 2021. The characteristics of the articles reveal groups consisting mostly of aged men, diagnosed with DM2, long-term Diabetes Mellitus and high risk stratification for ulceration 2/3<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>.</p>
					<p>The studies had follow-ups from six to 18 months. All studies evaluated the use of thermometry at home as a preventive method for diabetic foot ulcers compared to standard health care. The thermometry device used in all interventions was a handheld infrared digital thermometer (TempTouch, Diabetica Solutions, San Antonio, Texas, USA). The controls used standard foot care (follow-up with health professionals, foot care education, use of therapeutic footwear). <xref ref-type="table" rid="t3">Figure 2</xref> summarizes the characteristics of the studies included.</p>
					<p>
						<table-wrap id="t3">
							<label>Figure 2</label>
							<caption>
								<title>Characteristics of the RCTs included in the SR (n=5). Fortaleza, CE, Brazil, 2021</title>
							</caption>
							<table>
								<colgroup>
									<col/>
									<col/>
									<col span="3"/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="left">Author/ Year/ Country</th>
										<th align="left">Characteristics of the sample</th>
										<th align="left" colspan="3">Intervention Group/Control Group </th>
										<th align="left">Main results</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="left">Armstrong, et al.<xref ref-type="bibr" rid="B16"><sup>16</sup></xref> 2007. United States.</td>
										<td align="left">n=225 (IG*: 110, CG<sup>†</sup>: 115) Male: 96% Mean age: 69 years old DM2<sup>‡</sup>: 100% Mean time since DM diagnosis: 13 years Risk of ulcer: 2/3 (IWGDF<sup>§</sup>)</td>
										<td align="left">Duration: 18 months Outcomes: Proportion of patients in each group who developed foot ulcers</td>
										<td align="left">IG*: Handheld infrared thermometer and recording in diary </td>
										<td align="left">CG<sup>†</sup>: Therapeutic footwear, education on diabetes, regular foot care and recording in diary </td>
										<td align="left">Incidence of foot ulcers: IG*: 4.7% (n=5/NR<sup>||</sup>), CG<sup>†</sup>: 12.2% (n=14/NR<sup>||</sup>) </td>
									</tr>
									<tr>
										<td align="left">Bus, et al.<xref ref-type="bibr" rid="B31"><sup>31</sup></xref> 2021. Holland</td>
										<td align="left">n=304 (IG*: 151, CG<sup>†</sup>: 153) Male: 72.4% Mean age: 65 DM2<sup>‡</sup>: 77% Mean time since DM diagnosis: 20 years Risk of ulcer: 2/3 (IWGDF<sup>§</sup>)</td>
										<td align="left">Duration: 18 months Outcomes: Proportion of patients in each group who developed foot ulcers</td>
										<td align="left">IG*: Handheld infrared thermometer and recording in a standardized form developed by the researcher.</td>
										<td align="left">CG<sup>†</sup>: Foot assessment and foot screening once every 1-3 months by a podiatrist; therapeutic footwear (if indicated) and foot care education</td>
										<td align="left">Incidence of foot ulcers: IG*: 29.1% (n=44/151), CG<sup>†</sup>: 37.3% (n=57/153)</td>
									</tr>
									<tr>
										<td align="left">Lavery, et al.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> 2004. United States.</td>
										<td align="left">n=85 (IG*: 44, CG<sup>†</sup>: 41) Male: 50% Mean age: 55 years old DM2<sup>‡</sup>: NR Mean time since the diabetes diagnosis: 14 years Risk of ulcer: 2/3 (IWGDF<sup>§</sup>)</td>
										<td align="left">Duration: 06 months Outcomes: Proportion of patients in each group who developed foot ulcers, infections, Charcot fractures and amputations</td>
										<td align="left">IG*: Handheld infrared thermometer and recording in diary </td>
										<td align="left">GC<sup>†</sup>: Therapeutic footwear, foot care education, and regular assessment by a podiatrist every 10-12 weeks</td>
										<td align="left">Incidence of foot ulcers: IG*: 2% (n=1/44) CG<sup>†</sup>: 20% (n=9/41) (seven people presented ulcerations and two had Charcot arthropathies)</td>
									</tr>
									<tr>
										<td align="left">Lavery, et al.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref> 2007. United States.</td>
										<td align="left">n=173 (IG1: 59, IG2: 56, CG: 58) Male: 54% Mean age: 65 years old DM2<sup>‡</sup>: 95% Mean time since the diabetes diagnosis: 13 years Risk of ulcer: 2/3 (IWGDF<sup>§</sup>)</td>
										<td align="left">Duration: 15 months Outcomes: Proportion of patients in each group who developed foot ulcers</td>
										<td align="left">IG1: Handheld infrared thermometer and recording in diary. IG2: Mirror for self-inspection of the feet twice a day and recording in diary </td>
										<td align="left">CG<sup>†</sup>: Evaluation of the lower limbs (physician), program, therapeutic shoes and evaluation of insoles (podiatrist), pedometer and recording in diary; inspecting the feet daily</td>
										<td align="left">Incidence of foot ulcers: IG1: 8.5 (n=5/59) IG2: 30.4 (n=17/56) CG<sup>†</sup>: 29.3 (n=17/58)</td>
									</tr>
									<tr>
										<td align="left">Skafjeld, et al.<xref ref-type="bibr" rid="B28"><sup>28</sup></xref> 2015. Norway.</td>
										<td align="left">n=41 (IG*: 21, CG<sup>†</sup>: 20) Male: 56% Mean age: 58 years old DM2<sup>‡</sup>: 71% Mean time since the diabetes diagnosis: 18 years Risk of ulcer: 3 (IWGDF<sup>§</sup>)</td>
										<td align="left">Duration: 12 months Outcomes: Proportion of patients in each group who developed foot ulcers</td>
										<td align="left">IG*: Handheld infrared thermometer, recording in diary, theory-based counseling, and pedometer for recording physical activity in the first week of the study </td>
										<td align="left">GC<sup>†</sup>: Daily foot inspection and recording in diary; use of therapeutic footwear; contacting a nurse if changes were observed</td>
										<td align="left">Incidence of foot ulcers: IG*: 39% (n=7/21) CG<sup>†</sup>: 50% (n=10/20)</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<fn id="TFN3">
									<p>*IG = Intervention Group; <sup>†</sup>CG = Control Group; <sup>‡</sup>DM2 = Type 2 Diabetes Mellitus; <sup>§</sup>IWGDF = International Working Group on Diabetic Foot; <sup>||</sup>NR = Not Reported.</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
				</sec>
				<sec>
					<title>Risk of bias assessment</title>
					<p>The data were analyzed in <italic>Review Manager</italic> 5.4<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. As shown in <xref ref-type="fig" rid="f5">Figure 3</xref>, only one study has uncertain risk of bias for “random sequence generation”<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. Regarding the “allocation sequence”, one study presents a high risk of bias, as it does not mention the number of participants allocated to each group<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. In turn, two of the studies have uncertain risk of bias, as they present insufficient information<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref>. One study presented an uncertain risk of bias for the assessment of the “selective reporting” criteria<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>.</p>
					<p>
						<fig id="f5">
							<label>Figure 3</label>
							<caption>
								<title>Summary of the risk of bias for the studies included</title>
							</caption>
							<graphic xlink:href="1518-8345-rlae-30-e3567-gf5.png"/>
						</fig>
					</p>
				</sec>
				<sec>
					<title>Quantitative synthesis of the studies included: Meta-analysis</title>
					<p>Five RCTs involving 828 participants with diabetes were identified<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref>. In a study<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>, the number of participants randomized to the intervention group (thermometry) and control group (standard health care) was not mentioned and, therefore, it was not included in the meta-analysis.</p>
					<p>In this meta-analysis, four RCTs (n=547) were included, as shown in the forest plot graph (<xref ref-type="fig" rid="f6">Figure 4</xref>), and the prevention of the incidence of diabetic foot ulcers outcome was analyzed, presented as a binary outcome. The protective effect of thermometry was evidenced when compared to standard foot care to prevent the incidence of diabetic foot ulcers (RR 0.53; 95%CI 0.29-0.96; p=0.03). The heterogeneity between studies was I²=55% (p=0.08). The number of patients needing treatment to prevent the appearance of a new ulcer was 8 (95% CI = 5-19).</p>
					<p>
						<fig id="f6">
							<label>Figure 4</label>
							<caption>
								<title>Meta-analysis of the effect of thermometry when compared to standard health care in preventing the incidence of diabetic foot ulcers</title>
							</caption>
							<graphic xlink:href="1518-8345-rlae-30-e3567-gf6.png"/>
						</fig>
					</p>
				</sec>
				<sec>
					<title>Evidence certainty classification</title>
					<p>The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system<xref ref-type="bibr" rid="B30"><sup>30</sup></xref> was used to assess the certainty of the evidence and results presented in the GRADE evidence profile.</p>
					<p>
						<xref ref-type="table" rid="t4">Figure 5</xref> presents an assessment for the certainty of the evidence of the meta-analysis performed according to criteria previously defined by GRADE. As already stated, the estimate of the thermometry effect to prevent the incidence of diabetic foot ulcers was RR 0.53 when compared to standard health care, supported by moderate evidence.</p>
					<p>
						<table-wrap id="t4">
							<label>Figure 5</label>
							<caption>
								<title>Classification of the evidence certainty on the effect of thermometry for the prevention of diabetic foot ulcers. GRADEpro GDT. Fortaleza, CE, Brazil, 2021</title>
							</caption>
							<table>
								<colgroup>
									<col span="7"/>
									<col span="2"/>
									<col span="2"/>
									<col/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="center" colspan="7">Assessment of Certainty </th>
										<th align="center" colspan="2">No. of patients </th>
										<th align="center" colspan="2">Effect </th>
										<th align="center" rowspan="2">Certainty of the evidence </th>
										<th align="center" rowspan="2">Importance </th>
									</tr>
									<tr>
										<th align="left">No. of studies</th>
										<th align="left">Study design</th>
										<th align="left">Risk of bias</th>
										<th align="left">Inconsistency</th>
										<th align="left">Indirect evidence</th>
										<th align="left">Imprecision</th>
										<th align="left">Other considerations</th>
										<th align="left">Skin thermometry</th>
										<th align="left">Standard health care </th>
										<th align="left">Relative (95% CI*)</th>
										<th align="left">Absolute (95%CI*)</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="center" colspan="13">Preventing the incidence of diabetic foot ulcers (Follow-up: Mean of 12.8 months)</td>
									</tr>
									<tr>
										<td align="center">4</td>
										<td align="center">Randomized clinical trials</td>
										<td align="center">Not serious</td>
										<td align="center">Not serious</td>
										<td align="center">Not serious</td>
										<td align="center">Serious<sup>†</sup></td>
										<td align="center">None</td>
										<td align="center">57/275 (20.7%) </td>
										<td align="center">91/272 (33.5%) </td>
										<td align="center">RR<sup>‡</sup> 0.53 (From 0.29 to 0.96)</td>
										<td align="center">16 minus by 100 (from 24 minus to 1 minus)</td>
										<td align="center">ꚚꚚꚚꚚО Moderate</td>
										<td align="center">IMPORTANT</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<fn id="TFN4">
									<p>*CI = Confidence Interval; <sup>†</sup>Low number of events; <sup>‡</sup>RR = Relative Risk</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
				</sec>
			</sec>
			<sec sec-type="discussion">
				<title>Discussion</title>
				<p>As diabetic foot ulcer represents a global public health problem, the use of preventive strategies such as foot skin thermometry can contribute in the prevention of complications inherent to this problem. However, health professionals and patients need solid evidence to implement new care models. Therefore, we conducted an SR on the effect of thermometry in DFU prevention.</p>
				<p>Previous systematic reviews on the subject matter have already been published; however, there were inconsistencies regarding the methodological quality of the study included in the meta-analyses<xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref>. The RCT included in the meta-analyses does not specify how many individuals were allocated to the intervention group (use of thermometry) and to the control group (standard health care)<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. Thus, failures to provide a reliable numerical summary of the intervention’s effect are observed. In addition to that, searches in data sources and comprehensive evaluation of new evidence were necessary to provide reliable and robust information.</p>
				<p>Foot temperature was measured by the patients twice a day, in six specific regions of each foot (hallux, first, third and fifth metatarsal heads, midfoot and heel). In cases of amputations of a toe or metatarsal, temperature should be measured in an adjacent anatomical area. Temperature differences &gt;2.2°C between the corresponding left and right sites for two consecutive days were considered to be at risk of ulceration due to inflammation at the measurement site. Thus, the patients were advised to contact the study coordinator and reduce their activity until temperature normalized. In addition to that, they were required to make diary entries about foot temperature observations.</p>
				<p>When evaluating the outcome (incidence of foot ulcers), it was observed that in three studies there was an association of temperature monitoring with a reduction in the ulceration rate, suggesting that the thermometry used by the patients assists in the early identification of plantar inflammation before skin rupture and DFU formation<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. On the other hand, in two studies no differences were detected between the control and intervention groups<xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref>.</p>
				<p>In the RCT conducted by researchers from the United States, DFU incidence during a 15-month evaluation in the usual health care group was 29.3%<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. In contrast, in the group that monitored foot temperature at the same anatomical points daily, the incidence was 8.5% (OR 4.48; 95% CI 1.53-13.14; p&lt;0.008). </p>
				<p>In another study conducted by the same group of researchers, there were complications related to Charcot arthropathy (n=2)<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. However, it is recognized that active Charcot arthropathy has an individual effect on foot skin temperature. Therefore, the data from the Charcot arthropathy cases were excluded from the analysis. Of the 84 individuals followed-up for six months, seven participants in the standard therapy group were found to have presented ulcerations. However, in the group with foot temperature monitoring, only one individual presented ulcerations (OR 8.00; 95%CI). </p>
				<p>Temperature measurements can be easily performed by the patients or family members and can represent an effective adjuvant in DFU prevention. In addition to that, they provide quantifiable information that shows inflammation formation in specific foot regions so that preventive measures can be taken before skin ruptures. </p>
				<p>It was shown that 12.2% of the 115 participants in the standard care group had ulcers and only 4.7% of the 110 individuals in the thermometry group did so<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. Handheld thermometers can show positive results when used by high-risk patients to prevent ulcerative processes. This may offer an additional advantage to conventional DFU prevention practices and therapies. </p>
				<p>Half of the 10 people in the standard care group presented ulcerations and 39% of the 21 individuals in the temperature monitoring group presented the same outcome, with no significant intergroup differences (p=0.532)<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>. Although there were no intergroup differences in DFU recurrence, thermometry proved to be feasible for the patients. </p>
				<p>In the largest RCT on the topic up to date, 44 of 151 (29.1%) who used thermometry had a recurrent ulcer at a primary site, which was not significantly different from the 57 of 153 (37.3%) participants in the usual care group (RR 0.782; 95% CI 0.566-1.080; p=0.133). However, when the participants reduced their activity when an inflammation point was identified, the intervention proved to be effective over usual care<xref ref-type="bibr" rid="B31"><sup>31</sup></xref>. </p>
				<p>On the other hand, ensuring that the patients use the thermometer daily at their homes and refrain from all daily activities when the temperature of their feet is high is a potential challenge. Moreover, in the real world, adherence to the device for long periods of time can be lower than those recorded in this study.</p>
				<p>The summary of the effect of the intervention points to a reduction in the number of ulcers in the group using foot skin thermometry, when compared to the standard care group (RR=0.53; 95%CI 0.29-0.96; I²=55%; p=0.08). Although statistical heterogeneity is substantial (I²=55%), it should be noted that it is not statistically significant. </p>
				<p>The number of patients needed to be treated to prevent the appearance of a new skin ulcer was 8. This metric has been valuable in the clinical practice, especially in the selection of therapeutic interventions. It also has the potential to be used as a support tool in risk-benefit assessments and to help in health-related decision-making<xref ref-type="bibr" rid="B33"><sup>33</sup></xref>. Thus, skin thermometry represents an intervention that is easy to apply and its preventive role can contribute to the reduction of the high health costs and serious complications, such as hospitalizations, amputations and deaths. </p>
				<p>Estimating the efficacy of using thermometry in DFU prevention is supported by certainty of moderate evidence. Presence of imprecision was identified. It is recommended to lower the certainty of the evidence when the CI overlaps the null done line or the total number of events is less than 300. It should be noted that the estimates from the four studies included favor the intervention and that there is some overlap in the confidence intervals. In this case, it is not justified to lower the certainty of the evidence. However, the number of events is far from the recommended “optimal information size”<xref ref-type="bibr" rid="B34"><sup>34</sup></xref>. </p>
				<p>The strengths of this SR include explicit definition of the inclusion and exclusion criteria for the studies, use of a comprehensive and highly sensitive search strategy, rigorous screening and adherence to the PRISMA checklist, reliable numerical summary of the intervention’s effect, use of methodological quality assessment tools and supplementation with a GRADE evidence certainty assessment. This systematic and sensitive search made it possible to group interventions with similar characteristics. </p>
				<p>The treatment of diabetic foot ulcer complications and consequent lower limb amputations is always more expensive than investing in preventive measures and approaches to the foot at risk of ulceration. Therefore, thermal monitoring of the feet in people with diabetes has the potential to contribute to Clinical Nursing and to the interprofessional practice, by identifying imminent ulcerative processes, preventing new injuries, avoiding lower limb amputations and improving the individual’s quality of life, in addition to being able to reduce the burden on the health services and public expenditures. </p>
				<p>In this context, the implementation of skin thermometry assessment in the clinical protocol for the examination of individuals with diabetes is presented as a potential approach, due to its effectiveness in preventing ulcerations, in addition to being a non-invasive technique, requiring a short screening time, and with viable applicability. In addition, daily self-monitoring of dermal temperature by the patients or with the help of family members/caregivers can prevent occurrence and recurrence of diabetic foot ulcers.</p>
				<p>One of the limitations found in this research was that few studies met the inclusion criteria for this systematic review. The authors of this review contacted the authors of the studies included via the researchers’ digital platform (<ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/">https://www.researchgate.net/</ext-link>) to solve doubts, but received no answers. </p>
				<p>It is recommended that future research studies with larger samples be carried out to evaluate the use of this intervention; as well as that the cost of foot thermal monitoring in people with Diabetes Mellitus be also evaluated, via multicenter research studies in multiple social contexts. It is relevant to consider whether this intervention is profitable to a wider population in health services or at their homes. It is believed that implementing this new preventive approach can stand out in relation to the high financial costs with complications of diabetic plantar ulcers and lower limb amputations.</p>
				<p>New research studies on thermometry as a tool for the thermal assessment of the feet in people with diabetes are underway, and they can be followed-up via the <ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov/">https://www.clinicaltrials.gov/</ext-link>.</p>
			</sec>
			<sec sec-type="conclusions">
				<title>Conclusion</title>
				<p>It was evidenced that the use of infrared thermometers to monitor plantar temperature is a promising tool in the prevention of foot ulcers in people with Diabetes Mellitus. It is hoped that the findings of this systematic review with meta-analysis will sensitize and encourage managers, public health services, health professionals and patients/family members/caregivers to implement this preventive technique in the clinical and home contexts, as diabetic foot ulcers represent a high burden for the global public health.</p>
				<p>Incorporating this new preventive approach has the potential to contribute to the promotion of interdisciplinary and interprofessional care for the health team, in addition to promoting clinical decision-making, in conjunction with the patient’s wishes, improving their health conditions and contributing to the population and managers, by allowing planning, organization and reinforcement of new preventive strategies.</p>
			</sec>
		</body>
		<back>
			<fn-group>
				<fn fn-type="presented-at" id="fn6">
					<p>Paper extracted from master’s thesis “Efeito da termometria na prevenção de úlceras podálicas em pessoas com diabetes mellitus: revisão sistemática com metanálise”, presented to Universidade Estadual do Ceará, Fortaleza, CE, Brazil. This study was financed in part by the Coordenação de Aperfeiçoament o de Pessoal de Nível Superior (CAPES) - Finance Code 001, Brazil.</p>
				</fn>
				<fn fn-type="other">
					<label>Erratum</label>
					<p>In page 1, where was written:</p>
					<p>“Original Article”</p>
					<p>Now read:</p>
					<p>“Review Article”</p>
				</fn>
			</fn-group>
		</back>
	</sub-article>
	<sub-article article-type="translation" id="s2" xml:lang="es">
		<front-stub>
			<article-id pub-id-type="doi">10.1590/1518-8345.5663.3566</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Artículo de Revisión</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Efecto de la termometría en la prevención de las úlceras del pie diabético:</article-title>
				<subtitle>revisión sistemática con metaanálisis</subtitle>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-0100-0147</contrib-id>
					<name>
						<surname>Araújo</surname>
						<given-names>Açucena Leal de</given-names>
					</name>
					<xref ref-type="aff" rid="aff11"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff12"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-3150-2540</contrib-id>
					<name>
						<surname>Negreiros</surname>
						<given-names>Francisca Diana da Silva</given-names>
					</name>
					<xref ref-type="aff" rid="aff13"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-3119-7187</contrib-id>
					<name>
						<surname>Florêncio</surname>
						<given-names>Raquel Sampaio</given-names>
					</name>
					<xref ref-type="aff" rid="aff11"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff12"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-3902-8046</contrib-id>
					<name>
						<surname>Oliveira</surname>
						<given-names>Shérida Karanini Paz de</given-names>
					</name>
					<xref ref-type="aff" rid="aff11"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-5087-4310</contrib-id>
					<name>
						<surname>Silva</surname>
						<given-names>Ana Roberta Vilarouca da</given-names>
					</name>
					<xref ref-type="aff" rid="aff14"><sup>4</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-1424-0649</contrib-id>
					<name>
						<surname>Moreira</surname>
						<given-names>Thereza Maria Magalhães</given-names>
					</name>
					<xref ref-type="aff" rid="aff11"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff15"><sup>5</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff11">
				<label>1</label>
				<institution content-type="original"> Universidade Estadual do Ceará, Fortaleza, CE, Brasil.</institution>
			</aff>
			<aff id="aff12">
				<label>2</label>
				<institution content-type="original"> Bolsista da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brasil.</institution>
			</aff>
			<aff id="aff13">
				<label>3</label>
				<institution content-type="original"> Universidade Federal do Ceará, Fortaleza, CE, Brasil.</institution>
			</aff>
			<aff id="aff14">
				<label>4 </label>
				<institution content-type="original">Universidade Federal do Piauí, Picos, PI, Brasil.</institution>
			</aff>
			<aff id="aff15">
				<label>5</label>
				<institution content-type="original"> Bolsista do Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brasil.</institution>
			</aff>
			<author-notes>
				<corresp id="c3">
					<label>Autor de correspondencia:</label> Açucena Leal de Araújo. E-mail: <email>a.leal09@hotmail.com</email>
				</corresp>
				<fn fn-type="edited-by" id="fn9">
					<label>Editora Asociada</label>
					<p> Maria Lúcia Zanetti</p>
				</fn>
				<fn fn-type="con" id="fn11">
					<label>Contribución de los autores</label>
					<p><bold>Concepción y dibujo de la pesquisa:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Thereza Maria Magalhães Moreira. <bold>Obtención de datos:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Raquel Sampaio Florêncio, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva. <bold>Análisis e interpretación de los datos:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Raquel Sampaio Florêncio, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva, Thereza Maria Magalhães Moreira. <bold>Análisis estadístico:</bold> Açucena Leal de Araújo, Raquel Sampaio Florêncio, Thereza Maria Magalhães Moreira. <bold>Redacción del manuscrito:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva, Thereza Maria Magalhães Moreira. <bold>Revisión crítica del manuscrito en cuanto al contenido intelectual importante:</bold> Açucena Leal de Araújo, Francisca Diana da Silva Negreiros, Raquel Sampaio Florêncio, Shérida Karanini Paz de Oliveira, Ana Roberta Vilarouca da Silva, Thereza Maria Magalhães Moreira. Todos los autores aprobaron la versión final del texto.</p>
				</fn>
				<fn fn-type="conflict" id="fn12">
					<label>Conflicto de intereses</label>
					<p> Los autores han declarado que no existe ningún conflicto de intereses.</p>
				</fn>
			</author-notes>
			<abstract>
				<title>Resumen</title>
				<sec>
					<title>Objetivo:</title>
					<p> analizar el efecto de la termometría cutánea del pie en personas con diabetes mellitus, en comparación con la prevención estándar de las úlceras del pie adoptada en estos pacientes.</p>
				</sec>
				<sec>
					<title>Método:</title>
					<p> revisión sistemática con metaanálisis. Protocolo registrado en PROSPERO (CRD42020202686). Se siguieron las recomendaciones de <italic>Preferred Reporting Items for Systematic Reviews and Meta-Analyses</italic> (PRISMA). La búsqueda se realizó en las fuentes de datos: SCOPUS, <italic>Web of Science</italic>, MEDLINE a través de PubMed, MEDLINE a través de EBSCO, MEDLINE a través de la Biblioteca Virtual en Salud, Embase, CINAHL, <italic>Cochrane Library</italic>, LILACS a través de la Biblioteca Virtual en Salud, <italic>Google Scholar</italic>, Biblioteca Digital Brasileña de Tesis y Disertaciones, Catálogo de Tesis y Disertaciones-Capes, <italic>Open Grey</italic> y <italic>ProQuest Dissertations and Theses</italic>. El riesgo de sesgo se evaluó mediante la <italic>Cochrane Collaboration Risk of Bias Tool</italic> (RoB 2), el metaanálisis se realizó con el <italic>software Review Manager</italic> 5.4 y la certeza de la evidencia se evaluó mediante el sistema <italic>Grading of Recommendations Assessment, Development and Evaluation</italic>. </p>
				</sec>
				<sec>
					<title>Resultados:</title>
					<p> de los 670 registros, cinco artículos fueron elegibles. El metaanálisis se calculó para el resultado prevención de la incidencia de úlceras del pie diabético, con sumarización del efecto (RR 0,53; IC95% 0,29, 0,96; p=0,02), con certeza de evidencia moderada. </p>
				</sec>
				<sec>
					<title>Conclusión:</title>
					<p> la termometría mostró un efecto protector sobre la incidencia de úlceras del pie diabético en comparación con el cuidado estándar del pie.</p>
				</sec>
			</abstract>
			<kwd-group xml:lang="es">
				<title>Descriptores:</title>
				<kwd>Diabetes Mellitus</kwd>
				<kwd>Termometría</kwd>
				<kwd>Pie Diabético</kwd>
				<kwd>Prevención de Enfermedades</kwd>
				<kwd>Enfermería</kwd>
				<kwd>Revisión Sistemática</kwd>
			</kwd-group>
		</front-stub>
		<body>
			<boxed-text id="bx3">
				<sec>
					<title>Destacados</title>
					<p>(1) Las úlceras del pie diabético son precedidas por un aumento de la temperatura dérmica local.</p>
					<p>(2) La termometría puede ayudar en la identificación temprana de inflamación/ulceración.</p>
					<p>(3) Los pacientes/miembros de la familia pueden tomar fácilmente las mediciones de temperatura.</p>
					<p>(4) La termometría puede contribuir a reducir la sobrecarga de los servicios de salud.</p>
					<p>(5) La efectividad de la termometría se basa en la certeza de la evidencia moderada.</p>
				</sec>
			</boxed-text>
			<sec sec-type="intro">
				<title>Introducción</title>
				<p>Los abordajes actuales adoptados por los servicios de salud para la prevención y tratamiento precoz de las Úlceras del Pie Diabético (UPD) son múltiples y variados. La detección, la educación para la salud del paciente, la familia y los profesionales de la salud son pilares importantes<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>. Sin embargo, los esfuerzos para prevenir la UPD siguen siendo un desafío y tienen altos costos para la salud pública mundial<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B3"><sup>3</sup></xref>, lo que plantea la necesidad de nuevos enfoques preventivos.</p>
				<p>Las UPD son precedidas por un aumento de la temperatura dérmica local debido a la inflamación y autólisis tisular enzimática resultante del desequilibrio presión-actividad, a la que se le suma estrés repetitivo, pérdida sensorial neuropática y anomalías biomecánicas<xref ref-type="bibr" rid="B4"><sup>4</sup></xref>. Una diferencia de temperatura de 2,2ºC entre un mismo punto en ambos pies implica riesgo de úlcera/inflamación inminente<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>. Sin embargo, los signos clínicos de inflamación son sutiles para ser detectados por los pacientes o incluso por profesionales de la salud capacitados<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>. Aunque muchos signos de inflamación son difíciles de evaluar objetivamente, la temperatura se puede medir fácilmente.</p>
				<p>El método tradicional para evaluar la temperatura del pie es la palpación con el dorso de la mano. Sin embargo, con este método, los humanos solo somos capaces de discriminar diferencias de temperatura superiores a 2ºC. Por lo tanto, la termometría cutánea surge como una herramienta promisoria para la identificación de la inflamación, proporcionando señales precoces para prevenir la incidencia de UPD y reducir complicaciones graves, como alta morbilidad, hospitalizaciones frecuentes, amputación de miembros inferiores y muerte<xref ref-type="bibr" rid="B8"><sup>8</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B9"><sup>9</sup></xref>. Es el método más utilizado por la comunidad científica y los pacientes, dado que implica el uso de un termómetro, que es un instrumento de fácil aplicación y bajo costo<xref ref-type="bibr" rid="B10"><sup>10</sup></xref>. Con esto, los pacientes pueden modificar su actividad, midiendo la temperatura de la piel, además de dosificar la insulina y controlar la glicemia<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>.</p>
				<p>Un estudio reveló que hay una asociación entre el aumento de la temperatura local y la presión localizada, que causa daño tisular<xref ref-type="bibr" rid="B12"><sup>12</sup></xref>. Los investigadores utilizaron la termometría como herramienta para diagnosticar fracturas neuropáticas ocultas en pacientes con diabetes<xref ref-type="bibr" rid="B13"><sup>13</sup></xref>. La evaluación de la temperatura es una técnica útil para identificar pacientes con riesgo de ulceración<xref ref-type="bibr" rid="B14"><sup>14</sup></xref>. Se identificaron hallazgos similares con un termómetro infrarrojo portátil en pacientes con neuropatía sensorial asintomática, úlceras neuropáticas del pie y pacientes con fracturas neuropáticas (artropatía de Charcot)<xref ref-type="bibr" rid="B15"><sup>15</sup></xref>.</p>
				<p>La temperatura del pie varía según el nivel de actividad del paciente y el entorno. La referencia es un área correspondiente en el pie contralateral. Cabe destacar que las temperaturas de estas áreas no difieren en más de 1ºC<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref> y los estudios sugieren que diferencias de temperatura ≥ 2,2ºC pueden ser consideradas un riesgo de ulceración<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref>.</p>
				<p>En todo el mundo, tres Ensayos clínicos Controlados Aleatorizados (ECA) testearon el autocontrol de la temperatura cutánea del pie en personas con diabetes mellitus y su riesgo de ulceración, a través de la termometría infrarroja cutánea como señal de advertencia de una úlcera inminente. Estos estudios demostraron una reducción significativa en la incidencia de nuevas úlceras en los pies<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>.</p>
				<p>Revisiones sistemáticas anteriores han analizado el efecto de diversas intervenciones para prevenir las úlceras del pie diabético, incluido el uso de la monitorización térmica del pie<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref>. Si bien se identificaron revisiones sobre el tema, presentaban fallas a la hora de proporcionar resúmenes numéricos confiables de los efectos debido a limitaciones en la calidad de los estudios individuales. Además, desde entonces ha surgido nueva evidencia. Por lo tanto, fue necesario realizar una evaluación integral de los ECA que nos permitiera hacer el mejor uso de la evidencia actualmente disponible.</p>
				<p>Esta revisión sistemática con metaanálisis tuvo como objetivo analizar el efecto de la termometría cutánea del pie en personas con Diabetes Mellitus (DM), en comparación con la prevención estándar de las úlceras del pie adoptada en estos pacientes.</p>
			</sec>
			<sec sec-type="methods">
				<title>Método</title>
				<sec>
					<title>Protocolo y registro</title>
					<p>Se trata de una revisión sistemática de la literatura, según los criterios de <italic>Preferred Reporting Items for Systematic Reviews and Meta-Analyses</italic> (PRISMA)<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. Este tipo de estudio resume la evidencia de los estudios primarios realizados para responder a una pregunta de investigación específica. Utiliza un proceso de revisión de literatura integral, imparcial y reproducible, y localiza, evalúa y sintetiza el conjunto de las evidencias de los estudios científicos para obtener una visión general y una estimación confiable del efecto de la intervención<xref ref-type="bibr" rid="B23"><sup>23</sup></xref>.</p>
					<p>El protocolo de esta revisión fue previamente publicado en la plataforma <italic>International Prospective Register of Systematic Reviews</italic> (PROSPERO) de la <italic>York University</italic>, con número de registro CRD42020202686, obtenido el 4 de septiembre de 2020.</p>
				</sec>
				<sec>
					<title>Pregunta de investigación y criterios de elegibilidad</title>
					<p>Para la búsqueda de datos se utilizó la estrategia de <italic>Population, Intervention, Control</italic> y <italic>Outcome</italic> (PICO)<xref ref-type="bibr" rid="B24"><sup>24</sup></xref>. Esta revisión sistemática con metaanálisis se centró en los participantes (P) diagnosticados con diabetes mellitus, con o sin riesgo de desarrollar úlcera de pie diabético. Se dispuso como intervención (I) el uso de aparatos de termometría cutánea para evaluar la temperatura del pie. Se estableció como comparación (C) la implementación del cuidado médico estándar de los pies (calzado terapéutico, educación sobre el pie diabético, evaluación regular del pie por parte de profesionales de la salud y autocuidado del pie). Y los resultados evaluados (O) corresponden a los estudios cuyo resultado era la prevención de la incidencia de úlceras del pie diabético.</p>
					<p>A partir de eso, se delineó el problema de investigación: ¿Cuál es el efecto de la termometría cutánea del pie en personas con DM, en comparación con la prevención estándar de las úlceras del pie adoptada en estos pacientes?</p>
					<p>Se incluyeron los estudios que cumplían con los siguientes criterios: diagnóstico de DM, edad ≥ 18 años, ensayo clínico con grupo de intervención con termometría en la prevención de las Úlceras del Pie Diabético (DUP) y grupo control con cuidado médico estándar. No hubo restricciones en cuanto al idioma y año de publicación, ni en cuanto al riesgo de UPD (según la estratificación del <italic>International Working Group On The Diabetic Foot</italic>)<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>. Se descartaron las publicaciones con: estudio de intervención con termometría cutánea del pie en personas con y sin DM; termometría en personas con diabetes mellitus y úlcera activa simultáneamente; diseño del estudio: cohorte transversal, prospectivo y retrospectivo, casos y controles, informes de casos o series de casos; tipos de publicación: revisiones, protocolos, carta al editor, resúmenes de congresos, opiniones personales, capítulos de libros; no disponible en su totalidad.</p>
				</sec>
				<sec>
					<title>Búsqueda en fuente de datos</title>
					<p>La búsqueda se realizó en bases de datos y literatura gris el 26 de julio de 2020, sin restricciones de idioma y año. Se realizó una actualización de las búsquedas de fuentes de datos el 21 de noviembre de 2021. Se consultó a un bibliotecario familiarizado con las ciencias de la salud al desarrollar y realizar la investigación.</p>
					<p>Las bases de datos utilizadas fueron: SCOPUS, <italic>Web of Science</italic>, MEDLINE (<italic>Medical Literature Analysis and Retrieval System Online</italic>) a través de PubMed, MEDLINE (<italic>Medical Literature Analysis and Retrieval System Online</italic>) a través de EBSCO, MEDLINE (<italic>Medical Literature Analysis and Retrieval System Online</italic>) a través de la Biblioteca Virtual en Salud (BVS), Embase, CINAHL (<italic>Cummulative Index to Nursing and Allied Health Literature</italic>), <italic>Cochrane Library</italic> (<italic>The Cochrane Central Register of Controlled Trials</italic> - CENTRAL) y LILACS (Literatura Latinoamericana y del Caribe en Ciencias de la Salud) a través de la Biblioteca Virtual en Salud (BVS). </p>
					<p>Para reducir el sesgo de publicación e identificar la mayor cantidad de evidencia relevante posible, también se consultaron las bases de datos de literatura gris: <italic>Google Scholar</italic>, Biblioteca Digital Brasileña de Tesis y Disertaciones (BDTD), Catálogo de Tesis y Disertaciones - Capes, <italic>Open Grey</italic> y <italic>ProQuest Dissertations and Theses</italic> (PQDT).</p>
					<p>Además, fue necesaria una búsqueda adicional en las referencias de los estudios incluidos. También se realizó una búsqueda adicional en consulta con “expertos/especialistas” en el área de investigación a través de <ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/">https://www.researchgate.net/</ext-link>. Los mismos fueron invitados para que sugirieran artículos relevantes sobre el tema elegido. Sin embargo, no hubo respuestas.</p>
				</sec>
				<sec>
					<title>Estrategia de búsqueda</title>
					<p>La estrategia de búsqueda se construyó utilizando tres vocabularios de salud controlados <italic>Medical Subject Headings</italic> (MeSH), Descriptores en Ciencias de la Salud (DeCS) y EMTREE junto con el lenguaje natural, con el fin de obtener un amplio espectro de resultados en diferentes bases de datos<xref ref-type="bibr" rid="B25"><sup>25</sup></xref>. Después de definir los términos de búsqueda, se combinaron con los operadores booleanos AND y OR.</p>
					<p>Se utilizó la siguiente estrategia de búsqueda de alta sensibilidad para todas las bases de datos: (“diabetes mellitus” OR “diabetic patient” OR diabetes OR diabetic) AND (“temperature measurement” OR “temperature monitoring” OR “temperature recording” OR “thermal measurement” OR “thermal monitoring” OR “thermal recording” OR “thermo-monitoring” OR “thermo-recording” OR “body temperature monitoring” OR thermometer OR thermometry OR thermogram OR thermomonitoring OR thermorecording OR thermomeasurement) AND (prevention OR prevent OR control OR prophylaxis OR “prevent ulceration” OR “ulcer prevention” OR “prophylactic treatment” OR “preventive therapy” OR “preventive measures” OR “disease prevention” OR “disease prophylaxis” OR “health protection” OR “preventive treatment” OR “prophylactic management” OR “prophylactic therapy” OR “prophylactic treatment”) AND (foot OR ulcer OR ulceration OR feet OR “foot ulceration” OR “foot ulcer” OR “foot complication” OR “diabetic foot” OR “diabetic feet”).</p>
				</sec>
				<sec>
					<title>Selección de estudios y extracción de información</title>
					<p>Los resultados de la investigación en cada base de datos fueron importados al gestor de referencias Rayyan<sup>®</sup> desarrollado por el <italic>Qatar Computing Research Institute</italic> (QCRI), para la organización, eliminación de duplicados, selección y cribado de los estudios<xref ref-type="bibr" rid="B26"><sup>26</sup></xref>. Dos revisores examinaron de forma independiente los títulos y resúmenes de todas las referencias. Luego, los dos revisores evaluaron de forma independiente los textos completos de los estudios potencialmente elegibles para determinar si cumplían todos los criterios de inclusión. En caso de desacuerdo, se consultó a un tercer revisor.</p>
					<p>Los dos revisores extrajeron de forma independiente los datos de los estudios seleccionados para la muestra final y luego los compararon. Se utilizó un formulario clínico estandarizado creado en <italic>Microsoft Excel</italic><sup>®</sup> y, por último, los datos recolectados se compilaron en una tabla. Los datos que se recolectaron son: características del estudio (autor, año, país, objetivo); características de la población (muestra total, sexo, tipo de diabetes y media de edad), características del grupo de intervención y del grupo control (lugar de reclutamiento de la muestra, duración en meses, número de participantes en cada grupo, descripción de la intervención y del control), características de los resultados (resultados evaluados, principales resultados) y conclusión. Posteriormente, se compararon los resultados de la recolección y se discutió con el tercer revisor qué era realmente relevante. Cuando había información faltante, ambigua, incompleta o no descrita en los estudios primarios, se hizo lo posible por contactar a los autores.</p>
					<p>Se utilizó el diagrama de flujo <italic>Preferred Reporting Items for Systematic Reviews and Meta-Analyses</italic> (PRISMA) para documentar la selección de estudios.</p>
				</sec>
				<sec>
					<title>Análisis del riesgo de sesgo de los estudios individuales</title>
					<p>La evaluación del riesgo de sesgo de los estudios incluidos se analizó mediante la herramienta <italic>Cochrane Collaboration Risk of Bias Tool</italic> (RoB 2) para estudios aleatorizados<xref ref-type="bibr" rid="B27"><sup>27</sup></xref>. La RoB 2 incluye juicios sobre la generación de secuencias aleatorias, la ocultación de la asignación, el cegamiento de los participantes y el personal, el cegamiento de los evaluadores de resultados, datos de resultados incompletos, informe selectivo y otras fuentes de sesgo. Los estudios se clasificaron en grupos etiquetados como bajo riesgo de sesgo, riesgo incierto de sesgo o alto riesgo de sesgo.</p>
					<p>La novedad de la RoB 2 es considerar que no siempre es posible cegar a los participantes. Solo debemos considerar que baja la calidad de la evidencia si la falta de cegamiento afecta las intervenciones de forma desequilibrada entre los grupos y afecta los resultados<xref ref-type="bibr" rid="B27"><sup>27</sup></xref>. El análisis del riesgo de sesgo fue realizado por dos revisores independientes. En caso de discrepancias en el juicio de los dos revisores, se solicitó la evaluación del tercer revisor.</p>
					<p>Para resumir el análisis de riesgo de sesgo se utilizó la herramienta <italic>Cochrane Collaborations’s Review Manager 5</italic> (RevMan 5.4), que permitió la construcción del resumen de riesgo de sesgo<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>.</p>
				</sec>
				<sec>
					<title>Síntesis de los datos</title>
					<p>Se realizó una síntesis descriptiva de las características de los estudios. La síntesis cuantitativa de datos se realizó en un metaanálisis de los estudios considerados combinables y homogéneos en relación a las intervenciones y los resultados. Se utilizó <italic>Cochrane Collaboration´s Review Manager</italic><sup>®</sup> 5 (RevMan 5.4)<xref ref-type="bibr" rid="B28"><sup>28</sup></xref> para realizar el metaanálisis y fue presentado mediante el gráfico <italic>Forest Plot</italic>. La heterogeneidad presente en los estudios fue evaluada por la prueba estadística I2 de índices de inconsistencia, se consideró heterogeneidad poco importante al valor de 0-30%, heterogeneidad moderada de 31-50%, heterogeneidad sustancial de 51-80% y heterogeneidad considerable entre 81-100%<xref ref-type="bibr" rid="B29"><sup>29</sup></xref>. Los resultados se presentaron con intervalos de confianza del 95% (IC95%).</p>
					<p>Para realizar el metaanálisis se eligió el modelo de efectos aleatorios<xref ref-type="bibr" rid="B29"><sup>29</sup></xref>. Como medida de efecto, para los resultados binarios (el resultado puede ser 1 de 2 posibilidades) se utilizó el <italic>Risk Ratio</italic> (RR, o riesgo relativo), se consideró en este estudio la existencia o no de úlcera de pie diabético. Mientras que la estimación del efecto de los estudios individuales se calculó mediante el método estadístico de Mantel-Haenszel, que es ideal para los estudios con tamaños de muestra pequeños.</p>
				</sec>
				<sec>
					<title>Clasificación de la certeza de la evidencia</title>
					<p>En esta investigación se utilizó el sistema <italic>Grading of Recommendations Assessment, Development and Evaluation</italic> (GRADE) de Cochrane para clasificar la certeza de la evidencia<xref ref-type="bibr" rid="B30"><sup>30</sup></xref>. Los criterios evaluados fueron diseño del estudio, riesgo de sesgo, inconsistencia, evidencia indirecta, imprecisión y otras consideraciones. La certeza de la evidencia se puede caracterizar como alta, moderada, baja o muy baja. No se elaboró un gráfico de embudo para evaluar la presencia de sesgo de publicación porque los pocos ensayos clínicos aleatorizados fueron menos de diez.</p>
					<p>Se creó una tabla llamada “Perfil de evidencia GRADE” para resumir los hallazgos de esta evaluación. En este proceso se utilizó la herramienta en línea GRADEpro GDT (<italic>Guideline Development Tool</italic>), de libre acceso en la <italic>website</italic><ext-link ext-link-type="uri" xlink:href="http://www.gradepro.org">http://www.gradepro.org</ext-link>. </p>
				</sec>
			</sec>
			<sec sec-type="results">
				<title>Resultados</title>
				<sec>
					<title>Características de los estudios incluidos</title>
					<p>En total, se identificaron 670 registros. Después de eliminar los duplicados, quedaron 373 para la selección. Después de la revisión de títulos y resúmenes, se excluyeron 326 registros por no cumplir con los criterios de inclusión, lo que dejó 47 estudios potencialmente relevantes. De estos, 4 registros no se recuperaron en su totalidad, por lo que quedaron 43 para la revisión de texto completo. Por último, luego de la lectura completa, 38 no cumplieron con los criterios de elegibilidad, lo que dejó 5 estudios (<xref ref-type="fig" rid="f7">Figura 1</xref>). </p>
					<p>
						<fig id="f7">
							<label>Figura 1</label>
							<caption>
								<title>Diagrama de flujo de la búsqueda de acuerdo con las recomendaciones de PRISMA<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>
								</title>
							</caption>
							<graphic xlink:href="1518-8345-rlae-30-e3567-gf7.png"/>
						</fig>
					</p>
					<p>El resultado final fue la obtención de cinco Ensayos Clínicos Aleatorizados (ECA), con un total de 828 participantes, realizados en Estados Unidos<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>, Países Bajos<xref ref-type="bibr" rid="B31"><sup>31</sup></xref> y Noruega<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>, publicados en inglés, entre 2004 y 2021. Las características de los artículos revelan que los grupos estaban constituidos en su mayoría por hombres de la tercera edad diagnosticados con DM2, diabetes mellitus de larga evolución y estratificación de alto riesgo de ulceración 2/3<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>.</p>
					<p>El seguimiento de los estudios varió de seis a 18 meses. Todos los estudios evaluaron el uso de la termometría en el hogar como método preventivo para las úlceras del pie diabético y lo compararon con el cuidado médico estándar. El dispositivo de termometría utilizado en todas las intervenciones fue un termómetro digital infrarrojo portátil (<italic>TempTouch</italic>, <italic>Diabetica Solutions</italic> San Antonio, Texas, EE. UU.). En los controles se realizó el cuidado médico estándar de los pies (seguimiento con profesionales de la salud, educación sobre el cuidado de los pies, uso de calzado terapéutico). La <xref ref-type="table" rid="t5">Figura 2</xref> resume las características de los estudios incluidos.</p>
					<p>
						<table-wrap id="t5">
							<label>Figura 2</label>
							<caption>
								<title>Características de los ECR incluidos en la RS (n=5). Fortaleza, CE, Brasil, 2021</title>
							</caption>
							<table>
								<colgroup>
									<col/>
									<col/>
									<col span="3"/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="left">Autor/ año/país</th>
										<th align="left">Características de la muestra</th>
										<th align="left" colspan="3">Grupo Intervención / Grupo Control </th>
										<th align="left">Resultados principales</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="left">Armstrong, et al.<xref ref-type="bibr" rid="B16"><sup>16</sup></xref> 2007. Estados Unidos.</td>
										<td align="left">n=225 (GI*: 110, GC<sup>†</sup>: 115) Masculino: 96% Media de edad: 69 años DM2<sup>‡</sup>: 100% Duración media de la DM: 13 años Riesgo de úlcera: 2/3 (IWGDF<sup>§</sup>)</td>
										<td align="left">Duración: 18 meses Resultados: Proporción de pacientes en cada grupo que desarrolló úlceras en los pies</td>
										<td align="left">GI*: termómetro infrarrojo portátil y registro en diario </td>
										<td align="left">GC<sup>†</sup>: calzado terapéutico, educación sobre la diabetes, cuidado regular de los pies y registro en diario </td>
										<td align="left">Incidencia de úlceras en los pies: GI*: 4,7% (n=5/NI<sup>||</sup>), GC<sup>†</sup>: 12,2% (n=14/NI<sup>||</sup>) </td>
									</tr>
									<tr>
										<td align="left">Bus, et al.<xref ref-type="bibr" rid="B31"><sup>31</sup></xref> 2021. Países Bajos</td>
										<td align="left">n=304 (GI*: 151, GC<sup>†</sup>: 153) Masculino: 72,4% Media de edad: 65 años DM2<sup>‡</sup>: 77% Duración media de la DM: 20 años Riesgo de úlcera: 2/3 (IWGDF<sup>§</sup>)</td>
										<td align="left">Duración: 18 meses Resultados: Proporción de pacientes en cada grupo que desarrolló úlceras en los pies</td>
										<td align="left">GI*: termómetro infrarrojo portátil y registro en formulario estandarizado desarrollado por el investigador</td>
										<td align="left">GC<sup>†</sup>: evaluación de los pies y examen de los pies una vez cada 1 a 3 meses por un podólogo; calzado terapéutico (si está indicado) y educación sobre el cuidado de los pies</td>
										<td align="left">Incidencia de úlceras en los pies: GI*: 29,1% (n=44/151), GC<sup>†</sup>: 37,3 % (n=57/153)</td>
									</tr>
									<tr>
										<td align="left">Lavery, et al.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> 2004. Estados Unidos.</td>
										<td align="left">n=85 (GI*: 44, GC<sup>†</sup>: 41) Masculino: 50% Media de edad: 55 años DM2<sup>‡</sup>: NI Duración media de la diabetes: 14 años Riesgo de úlcera: 2/3 (IWGDF<sup>§</sup>)</td>
										<td align="left">Duración: 06 meses Resultados: Proporción de pacientes en cada grupo que desarrolló úlceras en los pies, infecciones, fracturas de Charcot y amputaciones</td>
										<td align="left">GI*: termómetro infrarrojo portátil y registro en diario</td>
										<td align="left">GC<sup>†</sup>: calzado terapéutico, educación sobre el cuidado de los pies y evaluación periódica por parte de un podólogo cada 10 a 12 semanas</td>
										<td align="left">Incidencia de úlceras en los pies: GI*: 2% (n=1/44) GC<sup>†</sup>: 20% (n=9/41) (siete personas presentaron úlceras y dos artropatías de Charcot)</td>
									</tr>
									<tr>
										<td align="left">Lavery, et al.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref> 2007. Estados Unidos.</td>
										<td align="left">n=173 (GI1: 59, GI2: 56, GC: 58) Masculino: 54% Media de edad: 65 años DM2<sup>‡</sup>: 95% Duración media de la diabetes: 13 años Riesgo de úlcera: 2/3 (IWGDF<sup>§</sup>)</td>
										<td align="left">Duración: 15 meses Resultados: Proporción de pacientes en cada grupo que desarrolló úlceras en los pies</td>
										<td align="left">GI1: termómetro infrarrojo portátil y registro en diario GI2: espejo para la autoinspección de los pies dos veces al día y registro en diario</td>
										<td align="left">GC<sup>†</sup>: evaluación de miembros inferiores (médico), programa, zapatos terapéuticos y evaluación de plantillas (podólogo), podómetro y registro en diario; revisar los pies diariamente</td>
										<td align="left">Incidencia de úlceras en los pies: GI1: 8,5 (n=5/59) GI2: 30,4 (n=17/56) GC<sup>†</sup>: 29,3 (n=17/58)</td>
									</tr>
									<tr>
										<td align="left">Skafjeld, et al.<xref ref-type="bibr" rid="B28"><sup>28</sup></xref> 2015. Noruega.</td>
										<td align="left">n=41 (GI*: 21, GC<sup>†</sup>: 20) Masculino: 56% Media de edad: 58 años DM2<sup>‡</sup>: 71% Duración media de la diabetes: 18 años Riesgo de úlcera: 3 (IWGDF<sup>§</sup>)</td>
										<td align="left">Duración: 12 meses Resultados: Proporción de pacientes en cada grupo que desarrolló úlceras en los pies</td>
										<td align="left">GI*: termómetro infrarrojo portátil y registro en diario, Asesoramiento basado en la teoría y podómetro para registrar la actividad física en la primera semana del estudio</td>
										<td align="left">GC<sup>†</sup>: inspección diaria de los pies y registro en diario; uso de calzado terapéutico; contactar a una enfermera si se observan cambios</td>
										<td align="left">Incidencia de úlceras en los pies: GI*: 39% (n=7/21) GC<sup>†</sup>: 50% (n=10/20)</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<fn id="TFN5">
									<p>*GI = Grupo Intervención; <sup>†</sup>GC = Grupo Control; <sup>‡</sup>DM2 = Diabetes Mellitus tipo 2; <sup>§</sup>IWGDF = <italic>International Working Group on Diabetic Foot</italic>; <sup>||</sup>NI = No Informado.</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
				</sec>
				<sec>
					<title>Evaluación del riesgo de sesgo</title>
					<p>Los datos se analizaron con el <italic>software Review Manager</italic> 5.4<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. Como se muestra en la <xref ref-type="fig" rid="f8">Figura 3</xref>, solo un estudio tiene riesgo incierto de sesgo en la “generación de secuencias aleatorias”<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. En lo que respecta a la “secuencia de asignación”, un estudio tiene alto riesgo de sesgo porque no menciona el número de participantes asignados a cada grupo<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. A su vez, dos de los estudios tienen riesgo de sesgo incierto, debido a que la información que presentan no es suficiente<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref>. Un estudio presentó riesgo incierto de sesgo en la evaluación de los criterios de “informe selectivo”<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>.</p>
					<p>
						<fig id="f8">
							<label>Figura 3</label>
							<caption>
								<title>Resumen del riesgo de sesgo de los estudios incluidos</title>
							</caption>
							<graphic xlink:href="1518-8345-rlae-30-e3567-gf8.png"/>
						</fig>
					</p>
				</sec>
				<sec>
					<title>Síntesis cuantitativa de los estudios incluidos: metaanálisis</title>
					<p>Se identificaron cinco ECA con 828 participantes con diabetes<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref>. En un estudio<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>, el número de participantes asignados al azar al grupo de intervención (termometría) y al grupo control (cuidado médico estándar) no fue mencionado y, por lo tanto, no fue incluido en el metaanálisis.</p>
					<p>En este metaanálisis, se incluyeron cuatro ECA (n = 547), como se muestra en el gráfico <italic>Forest Plot</italic> (<xref ref-type="fig" rid="f9">Figura 4</xref>), y se analizó el resultado prevención de la incidencia de úlceras del pie diabético, presentado como resultado binario. Se observó que la termometría tuvo un efecto protector en comparación con el cuidado estándar de los pies para prevenir la incidencia de úlceras del pie diabético (RR 0,53; IC95% 0,29-0,96; p=0,03). La heterogeneidad entre los estudios fue I²=55% (p=0,08). El número de pacientes que requirió tratamiento para prevenir la aparición de nuevas úlceras fue 8 (IC 95% = 5-19).</p>
					<p>
						<fig id="f9">
							<label>Figura 4</label>
							<caption>
								<title>Metaanálisis del efecto de la termometría en comparación con el cuidado médico estándar para la prevención de la incidencia de úlceras del pie diabético</title>
							</caption>
							<graphic xlink:href="1518-8345-rlae-30-e3567-gf9.png"/>
						</fig>
					</p>
				</sec>
				<sec>
					<title>Clasificación de la certeza de la evidencia</title>
					<p>Se utilizó el sistema <italic>Grading of Recommendations Assessment, Development and Evaluation</italic> (GRADE)<xref ref-type="bibr" rid="B30"><sup>30</sup></xref> para evaluar la certeza de la evidencia y los resultados presentados en el perfil de evidencia GRADE.</p>
					<p>La <xref ref-type="table" rid="t6">Figura 5</xref> presenta la evaluación de la certeza de la evidencia del metaanálisis realizado según criterios previamente definidos por GRADE. Como se indicó anteriormente, la estimación del efecto de la termometría para prevenir la incidencia de úlceras del pie diabético fue RR 0,53, en comparación con el cuidado médico estándar, respaldada por evidencia moderada.</p>
					<p>
						<table-wrap id="t6">
							<label>Figura 5</label>
							<caption>
								<title>Clasificación de la certeza de la evidencia sobre el efecto de la termometría para la prevención de las úlceras del pie diabético. GRADEpro GDT. Fortaleza, CE, Brasil, 2021</title>
							</caption>
							<table>
								<colgroup>
									<col span="7"/>
									<col span="2"/>
									<col span="2"/>
									<col/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="center" colspan="7">Evaluación de la Certeza </th>
										<th align="center" colspan="2">Nºde pacientes </th>
										<th align="center" colspan="2">Efecto </th>
										<th align="center" rowspan="2">Certeza de la evidencia </th>
										<th align="center" rowspan="2">Importancia</th>
									</tr>
									<tr>
										<th align="center">N<sup>o</sup>. de estudios</th>
										<th align="center">Diseño del estudio</th>
										<th align="center">Riesgo de sesgo</th>
										<th align="center">Inconsistencia</th>
										<th align="center">Evidencia indirecta</th>
										<th align="center">Imprecisión</th>
										<th align="center">Otras consideraciones</th>
										<th align="center">Termometría cutánea</th>
										<th align="center">Cuidado médico estándar</th>
										<th align="center">Relativo (95% IC*)</th>
										<th align="center">Absoluto (95% IC*)</th>
									</tr>
									<tr>
										<th align="center" colspan="13">Prevención de la incidencia de úlceras del pie diabético (seguimiento: media 12,8 meses)</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="center">4</td>
										<td align="center">ensayos clínicos aleatorizados</td>
										<td align="center">no grave</td>
										<td align="center">no grave</td>
										<td align="center">no grave</td>
										<td align="center">grave<sup>†</sup></td>
										<td align="center">ninguna</td>
										<td align="center">57/275 (20.7%)</td>
										<td align="center">91/272 (33.5%)</td>
										<td align="center">RR<sup>‡</sup> 0.53 (0.29 para 0.96)</td>
										<td align="center">16 menos por 100 (de 24 menos a 1 menos)</td>
										<td align="center">ꚚꚚꚚꚚО Moderada</td>
										<td align="center">IMPORTANTE</td>
									</tr>
								</tbody>
							</table>
							<table-wrap-foot>
								<fn id="TFN6">
									<p>*IC = Intervalo de Confianza; <sup>†</sup>Bajo número de eventos; <sup>‡</sup>RR = Riesgo Relativo</p>
								</fn>
							</table-wrap-foot>
						</table-wrap>
					</p>
				</sec>
			</sec>
			<sec sec-type="discussion">
				<title>Discusión</title>
				<p>Como la úlcera del pie diabético representa un problema de salud pública mundial, el uso de estrategias preventivas como la termometría de la piel del pie puede contribuir a la prevención de este problema y del agravamiento del mismo. Sin embargo, los profesionales de la salud y los pacientes necesitan evidencia sólida para implementar nuevos modelos de atención. Por lo tanto, realizamos la RS del efecto de la termometría en la prevención de UPD.</p>
				<p>Se publicaron revisiones sistemáticas anteriores sobre el tema, sin embargo, hubo inconsistencias en cuanto a la calidad metodológica de un estudio incluido en los metaanálisis<xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref>. El ECA incluido en los metaanálisis no especifica cuántos individuos fueron asignados al grupo de intervención (uso de termometría) y al grupo control (cuidado médico estándar)<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. Por consiguiente, se observan fallas debido a que no hay un resumen numérico confiable del efecto de la intervención. Además, fue necesario realizar búsquedas en las fuentes de datos y una evaluación exhaustiva de la nueva evidencia para proporcionar información confiable y sólida.</p>
				<p>Los pacientes midieron la temperatura del pie dos veces al día, en seis regiones específicas de cada pie (hallux, cabezas de los primero, tercero y quinto metatarsianos, parte media del pie y talón). En casos de amputación de un dedo del pie o metatarsiano, la temperatura debe medirse en un área anatómica adyacente. Se consideró que cuando había una diferencia de temperatura &gt;2,2 °C entre los sitios equivalentes izquierdo y derecho durante dos días consecutivos había riesgo de ulceración debido a la inflamación en el sitio de la medición. Por lo tanto, se les aconsejó a los pacientes que contactaran al coordinador del estudio y redujeran la actividad hasta que la temperatura se normalizara. Además, se les pidió a los pacientes que realizaran anotaciones en el diario sobre las observaciones de la temperatura del pie.</p>
				<p>Al evaluar el resultado (incidencia de úlceras del PD), se observó que en tres estudios hubo asociación entre el monitoreo de la temperatura y la reducción de la tasa de ulceración, lo que sugiere que la termometría utilizada por los pacientes ayuda en la identificación temprana de la inflamación plantar antes de la ruptura de la piel y la formación de la UPD<xref ref-type="bibr" rid="B11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. Por otro lado, en dos estudios no se detectaron diferencias entre los grupos control e intervención<xref ref-type="bibr" rid="B31"><sup>31</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref>.</p>
				<p>En el ECA realizado por investigadores de los Estados Unidos, la incidencia de UPD durante una evaluación de 15 meses en el grupo de cuidado médico habitual fue del 29,3%<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. En cambio, en el grupo que controló diariamente la temperatura del pie en los mismos puntos anatómicos, la incidencia fue del 8,5% (OR 4,48; IC 95%; 1,53-13,14; p&lt;0,008).</p>
				<p>En otro estudio realizado por el mismo grupo de investigadores, hubo complicaciones relacionadas con la artropatía de Charcot (n=2)<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. Sin embargo, se reconoce que la artropatía de Charcot activa tiene un efecto individual sobre la temperatura de la piel del pie. Por lo tanto, los datos de los casos de artropatía de Charcot se excluyeron del análisis. Se descubrió que de los 84 sujetos a los que se le realizó seguimiento durante seis meses, siete participantes del grupo de cuidado médico estándar tenían ulceración. Sin embargo, en el grupo con control de la temperatura del pie, solo un individuo presentó ulceración (OR 8,00; IC del 95 %).</p>
				<p>Las mediciones de temperatura pueden ser realizadas fácilmente por pacientes o familiares y pueden representar un complemento eficaz en la prevención de UPD. Además, brindan información cuantificable que demuestra la formación de inflamación en regiones específicas del pie y permite que se puedan tomar medidas preventivas antes de que la piel se rompa.</p>
				<p>Se demostró que el 12,2% de 115 participantes en el grupo de cuidado estándar presentaron ulceraciones y que solo les ocurrió al 4,7% de 110 individuos en el grupo de termometría<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. Los termómetros portátiles pueden demostrar resultados positivos cuando los utilizan los pacientes de alto riesgo para prevenir procesos ulcerativos. Esto puede ofrecer una ventaja adicional a las prácticas y terapias de prevención de UPD convencionales.</p>
				<p>La mitad de las 10 personas en el grupo de cuidado estándar presentaron ulceraciones y el 39% de las 21 personas en el grupo de control de temperatura también, esto indica que no hubo diferencias significativas entre los grupos (p=0,532)<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>. Aunque no hubo diferencias entre los grupos en la recurrencia de UPD, la termometría resultó viable para los pacientes.</p>
				<p>En el ECA más grande sobre el tema hasta la fecha, 44 de los 151 (29,1%) participantes que usaron termometría presentaron una úlcera recurrente en un sitio primario, lo que no difirió significativamente de los 57 de 153 (37,3%) participantes en el grupo de cuidado habitual (RR 0,782, IC 95% 0,566-1,080, p = 0,133). Pero cuando los participantes redujeron su actividad al identificar un punto crítico, la intervención demostró ser más efectiva que la atención habitual<xref ref-type="bibr" rid="B31"><sup>31</sup></xref>.</p>
				<p>Por otro lado, garantizar que los pacientes usen el termómetro diariamente en casa y se abstengan de todas las actividades diarias cuando la temperatura de los pies es alta es un desafío potencial. Además, en el mundo real, la adherencia al dispositivo durante períodos prolongados puede ser inferior a la registrada en este estudio.</p>
				<p>El resumen del efecto de la intervención indica que hubo una reducción en el número de úlceras en el grupo con termometría cutánea del pie, en comparación con el grupo que realiza el cuidado estándar (RR=0,53; IC95%, 0,29-0,96; I²=55%; p=0,08). Aunque la heterogeneidad estadística es sustancial (I2=55%), cabe señalar que no es estadísticamente significativa.</p>
				<p>El número de pacientes que requirió tratamiento para prevenir la aparición de una nueva úlcera cutánea fue 8. Esta métrica ha sido valiosa en la práctica clínica, especialmente para la selección de intervenciones terapéuticas. También tiene el potencial de ser utilizada como una herramienta de apoyo en las evaluaciones de riesgo-beneficio y para ayudar en la toma de decisiones en salud<xref ref-type="bibr" rid="B33"><sup>33</sup></xref>. Por lo tanto, la termometría cutánea representa una intervención de fácil aplicación y su rol preventivo puede contribuir a reducir los altos costos en salud y las complicaciones graves, como hospitalización, amputación y muerte.</p>
				<p>La estimación de la efectividad del uso de la termometría en la prevención de la UPD está respaldada por la certeza de evidencia moderada. Se identificó la presencia de imprecisión. Se recomienda disminuir la certeza de la evidencia cuando el IC se superpone a la línea de efecto nulo o el número total de eventos es inferior a 300. Cabe señalar que las estimaciones de los cuatro estudios incluidos favorecen la intervención y existe cierta superposición en los intervalos de confianza. En este caso, no se justifica disminuir la certeza de la evidencia. Sin embargo, el número de eventos está lejos del “tamaño óptimo de información” (<italic>optimal information size</italic>) recomendado<xref ref-type="bibr" rid="B34"><sup>34</sup></xref>. </p>
				<p>Los puntos fuertes de esta RS incluyen la definición explícita de los criterios de inclusión y exclusión para los estudios, el uso de una estrategia de búsqueda integral y altamente sensible, la selección rigurosa y el cumplimiento de la lista de verificación PRISMA, un resumen numérico confiable del efecto de la intervención, el uso de herramientas de evaluación de la calidad metodológica y complementar con la evaluación de certeza de la evidencia GRADE. La búsqueda sistemática y sensible permitió agrupar intervenciones con características similares.</p>
				<p>El tratamiento de las complicaciones de la úlcera del pie diabético y la consecuente amputación de miembros inferiores es siempre más costoso que invertir en medidas preventivas y de abordaje del pie con riesgo de ulceración. Por lo tanto, el monitoreo térmico de los pies en personas con diabetes tiene el potencial de contribuir a la práctica clínica de enfermería e interprofesional, al identificar procesos ulcerativos inminentes, prevenir nuevas lesiones, evitar amputaciones de miembros inferiores y mejorar la calidad de vida del individuo, además tiene el poder de reducir la carga de los servicios de salud y el gasto público.</p>
				<p>En este contexto, la implementación de la evaluación de la termometría cutánea en el protocolo clínico para el examen de personas con diabetes se presenta como un abordaje potencial, debido a su efectividad en la prevención de la ulceración, además es una técnica no invasiva, que requiere un corto tiempo de triaje, y cuya aplicabilidad es viable. También el autocontrol diario de la temperatura dérmica por parte de los pacientes o con la ayuda de familiares/cuidadores puede prevenir la aparición y recurrencia de las úlceras del pie diabético.</p>
				<p>Se consideran limitaciones de la presente investigación que pocos estudios cumplieron con los criterios de inclusión para esta revisión sistemática. Los autores de esta revisión contactaron a los autores de los estudios incluidos a través de la plataforma digital de los investigadores <ext-link ext-link-type="uri" xlink:href="https://www.researchgate.net/">https://www.researchgate.net/</ext-link> para resolver dudas, pero no recibieron respuesta. </p>
				<p>Se recomienda realizar futuras investigaciones con muestras más amplias para evaluar el uso de esta intervención. Y que también se evalúe el costo del monitoreo térmico del pie en personas con diabetes mellitus, a través de investigaciones multicéntricas en múltiples contextos sociales. Es relevante considerar si esta intervención es rentable para una población más amplia en los servicios de salud o en el domicilio. Se cree que la implementación de este nuevo enfoque preventivo puede destacarse en relación con los altos costos financieros que tienen las complicaciones de las úlceras plantares diabéticas y las amputaciones de las extremidades inferiores.</p>
				<p>Están en marcha nuevas investigaciones sobre la termometría como herramienta para la evaluación térmica de los pies en personas con diabetes, y se puede realizar el seguimiento de las mismas a través de la plataforma <ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov/">https://www.clinicaltrials.gov/</ext-link>.</p>
			</sec>
			<sec sec-type="conclusions">
				<title>Conclusión</title>
				<p>Se observó que el uso de termómetros infrarrojos para monitorear la temperatura plantar es una herramienta promisoria para la prevención de úlceras en los pies en personas con diabetes mellitus. Se espera que los hallazgos de esta revisión sistemática con metaanálisis sensibilicen y animen a gestores, servicios de salud pública, profesionales de la salud y pacientes/familiares/cuidadores a implementar esta técnica preventiva en el contexto clínico y domiciliario, dado que las úlceras del pie diabético representan una gran carga para la salud pública mundial.</p>
				<p>La incorporación de este nuevo enfoque preventivo tiene el potencial de contribuir a la promoción del cuidado interdisciplinario e interprofesional del equipo de salud, además de promover la toma de decisiones clínicas, en conjunto con los deseos del paciente, mejorar sus condiciones de salud y colaborar con la población y los gestores, al permitir planificar, organizar y reforzar nuevas estrategias preventivas. </p>
			</sec>
		</body>
		<back>
			<fn-group>
				<fn fn-type="presented-at" id="fn10">
					<p>Artículo parte de la disertación de maestría “Efeito da termometria na prevenção de úlceras podálicas em pessoas com diabetes mellitus: revisão sistemática com metanálise”, presentada en la Universidade Estadual do Ceará, Fortaleza, CE, Brasil. El presente trabajo fue realizado con apoyo de la Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) - Código de Financiamiento 001, Brasil.</p>
				</fn>
				<fn fn-type="other">
					<label>Fe de Erratas</label>
					<p>En la página 1, donde se leía:</p>
					<p>“Artículo Original”</p>
					<p>Leer:</p>
					<p>“Artículo de Revisión”</p>
				</fn>
			</fn-group>
		</back>
	</sub-article>
</article>